netFormulary
 Report : A-Z of formulary items 26/05/2018 12:38:02
[Back]
 
Section Name Details
24.01 Palivizumab IM Syringe Synagis®
05.03.01 Abacavir Ziagen®
05.03.01 Abacavir and Lamivudine Kivexa® Tablets
05.03.01 Abacavir and Lamivudine and Zidovudine Trizivir®
06.01.01.02 Abasaglar® Insulin glargine 3mL pre-filled disposible pen (KwikPen®)
3mL cartridge

**First line insulin glargine in NEW PATIENTS**
10.01.03 Abatacept  Intravenous infusion

Supplied via homecare arrangements
24.03 Abatacept IV Infusion 
02.09 Abciximab  Injection
04.10.01 Acamprosate  Gastro-resistant tablets

Green Traffic Light Only in conjunction with specialist service
06.01.02.03 Acarbose Glucobay® Tablets
02.08.02 Acenocoumarol Sinthrome® Tablets
02.08.02 Acenocoumarol Sinthrome® Tablets
11.06 Acetazolamide Diamox® Tablets
Sustained release capsules
Injection

Restricted Item Ophthalmic specialist initiation only
12.01.01 Acetic Acid 2% Earcalm ® Ear Spray
11.08.02 Acetylcholine Chloride  Intraocular irrigation
05.03.02.01 Aciclovir  Tablets
Suspension
Intravenous Infusion
11.03.03 Aciclovir   Eye ointment

13.10.03 Aciclovir Zovirax® Cream
13.05.02 Acitretin Neotigason® Capsules

Restricted Item Dermatology only
03.01.02 Aclidinium Eklira Genuair® Inhaler 400 micrograms/dose

03.01.04 Aclidinium / Formoterol Duaklir® Genuair Combination LABA/LAMA inhaler
06.01.01.01 Actrapid®  10ml vial
01.05.03 Adalimumab Humira®
10.01.03 Adalimumab  Subcutaneous Injection

Supplied via homecare arrangements
13.05.03 Adalimumab Humira®
09.05.01.01 Adcal®  Chewable tablets
05.03.03.01 Adefovir Dipivoxil Hepsera®
02.03.02 Adenosine Adenocor® Injection
Infusion
02.07.03 Adrenaline / Epinephrine  Injection
03.04.03 Adrenaline / epinephrine  DotInjection (IM/SC)
DotInjection (IV) Extreme caution
Restricted Item Intravenous adrenaline should only be given by those experienced in its use, in a setting where patients can be carefully monitored. See BNF for more information. DotIntramuscular injection for self-administration (auto-injector) (EpiPen®, Jext®)
It is advisable to prescribe adrenaline auto-injector by brand to avoid confusion.



11.08.02 Aflibercept Eylea® Intravitreal injection

Restricted Item Ophthalmic consultant only

Use as per GMMMMG Macular Drugs Pathway
04.03.04 Agomelatine  Restricted Item Agomelatine may have a role for specialist initiation, but only in those patients with severe depression who have already failed on all classes of antidepressant therapies.
05.05.01 Albendazole  Tablets

unlicensedunlicensed
05.05.03 Albendazole  Tablets

unlicensedunlicensed
05.05.04 Albendazole  See section 5.5.1.
05.05.07 Albendazole  Tablets

unlicensedunlicensed
05.05.08 Albendazole  Tablets

unlicensedunlicensed
08.02.03 Alemtuzumab MabCampath® Concentrate for intravenous infusion

Restricted Item Specialist use only

Patient access scheme may be available. Patient access and monitoring form available from pharmacy.
24.03 Alemtuzumab IV Infusion 
24.03 Alemtuzumab SC Injection 
06.06.02 Alendronic Acid  70mg tablets (once weekly preparation)

09.06.04 Alfacalcidol One-Alpha® Capsules
Oral Solution

For maintenance, not for treatment.

Green Traffic Light Frequency of plasma calcium monitoring should be determined by secondary care clinicians and communicated to primary care
15.01.04.03 Alfentanil Rapifen®
07.04.01 Alfuzosin  M/R tablets
03.04.01 Alimemazine  Tablets
Oral Solution

Restricted Item On formulary for paediatric use only

02.12 Alirocumab Praluent® Pre-filled syringe
Pre-filled pen
Restricted Item For patients with latex allergy or intolerance to evolocumab

Only as per NICE TA393.
Requires completion of Blueteq form prior to initiation.
Available via Homecare providers.

13.05.01 Alitretinoin Toctino® Capsules

Restricted Item Dermatology (Salford Royal) only
10.01.04 Allopurinol  Tablets
06.01.02.03 Alogliptin Vipidia® Tablets

09.06.05 Alpha Tocopheryl Acetate  Oral suspension
13.09 Alphosyl 2 in 1® Coal Tar Extract 5% (Alcoholic) Shampoo
07.04.05 Alprostadil  Caverject® intracavernosal injection
MUSE® urethral application
02.10.02 Alteplase Actilyse® Actilyse Injection

Restricted ItemActilyse Cathflo 2mg (for thrombolytic treatment of occluded central venous access devices)is restricted to  NMGH Renal Unit only;

Approved for pulmonary embolism, acute ischaemic stroke (FGH only) and thrombolysis in acute limb ischaemia.

Alteplase is recommended for the treatment of acute ischaemic stroke in adults in accordance with its licensed indication if:
  • treatment is started as early as possible within 4.5 hoursof onset of stroke symptoms, AND
  • intracranial haemorrhage has been excluded by appropriate imaging techniques
  • See NICE TA264
    13.12 Aluminimum Chloride Hexahydrate 20% in Alcoholic Base Anhydrol Forte® or Driclor®
    09.05.02.02 Aluminium Hydroxide Alu-Cap® 475mg capsules

    01.02 Alverine Citrate Spasmonal®
    04.09.01 Amantadine Hydrochloride  Capsules
    Syrup
    24.01 Ambisome IV Infusion 
    24.01 Ambisome IV Syringe 
    24.01 Ambisome IV Syringe 1mg/ml 
    05.01.04 Amikacin  Injection

    Restricted Item Can only be prescribed for intravenous use following discussion with the Consultant Microbiologist or ID Physician
    02.02.03 Amiloride   Tablets
    Liquid

    13.08.01 Aminolevulinic acid  Metvix Cream

    Restricted Item Dermatology Only
    03.01.03 Aminophylline  Modified release tablets

    Red Traffic Light  Injection


    02.03.02 Amiodarone  Tablets
    Infusion
    Injection (emergency use only)

    Restricted Item Specialist initiation only

    04.02.01 Amisulpride  Tablets
    Oral solution

    Red Traffic Light RED when prescribed for new patients with dementia or other unlicensed indications
    04.03.01 Amitriptyline  Tablets
    Oral solution
    04.07.03 Amitriptyline  Tablets
    Oral solution
    06.01.05 Amitriptyline  Tablets
    Oral solution

    unlicensedunlicensed
    02.06.02 Amlodipine  Tablets
    13.10.02 Amorolfine Loceryl® Restricted Item Dermatology Only
    05.01.01.03 Amoxicillin  Capsules
    Oral Suspension
    Sachets
    Injection
    05.02.03 Amphotericin AmBisome® Intravenous Infusion

    Prepared by pharmacy aseptics during working hours. Liaise with pharmacy.
    24.03 Amsacrine IV Infusion 
    09.01.04 Anagrelide Xagrid® Capsules
    08.03.04.01 Anastrozole Arimidex® Tablets

    11.04.02 Antazoline 0.5% with Xylometazoline 0.05% Otrivine-Antistin® Eye drops
    13.08.01 Anthelios® Melt In Cream SPF50  Cream

    Restricted Item Dermatology Only
    14.05.03 Anti-D (Rh0) Immunoglobulin 
    09.01.03 Anti-human thymocyte immunoglobulin (rabbit)  Thymoglobuline®
    01.07.01 Anusol®   Cream
    Suppositories
    01.07.02 Anusol-HC®  Ointment
    Suppositories
    06.01.01.01 Apidra® Insulin Glulisine 3ml cartridge (via ClikSTAR® or Autopen® 24)
    3ml pre-filled disposable pen (SoloStar®)
    02.08.02 Apixaban Eliquis Tablets
    02.08.02 Apixaban Eliquis Tablets
    04.09.01 Apomorphine Injection  Initiation on the recommendation of a movement disorder specialist only
    11.06 Apraclonidine Iopidine® Eye drops

    Restricted Item Ophthalmic consultant initiation only: Apraclonidine can be used long term for certain complex glaucoma cases where surgery is high risk. See also section 11.8.

    unlicensed 1% - unlicensed use
    11.08.02 Apraclonidine Iopidine® 0.5% Eye drops
    1% Single-use eye drops

    Apraclonidine 1% is licensed for control or prevention of postoperative elevation of intraocular pressure after anterior segment laser surgery.

    See also section 11.06.

    Restricted Item Ophthalmic specialist initiation only
    10.01.03 Apremilast Otezla® Tablets
    13.02.01.01 Aqueous Cream BP 
    06.02.02 Aqueous Iodine Oral Solution Lugol's Oral solution
    01.06.03 Arachis Oil Enema 
    04.02.01 Aripiprazole  Tablets
    Orodispersible tablets
    Oral solution
    Injection (IM)

    Red Traffic Light RED when prescribed for new patients with dementia or other unlicensed indications
    04.02.02 Aripiprazole  Abilify Maintena® Vial
    24.03 Arsenic Trioxide IV Infusion 
    05.04.01 Artemether with lumefantrine Riamet® Tablets
    05.04.01 Artesunate  Injection
    unlicensedunlicensed
    09.06.03 Ascorbic Acid  Tablets
    04.02.03 Asenapine  Sublingual tablets

    Restricted Item Pennine Care: may be considered third line for inpatients who have failed to respond or failed to tolerate existing therapies.
    02.09 Aspirin (antiplatelet)  Dispersible tablets
    Gastro-resistant (enteric coated) tablets (only for patients established on this product)
    Tablets

    See information above.

    Low dose aspirin prophylaxis should not routinely be initiated for primary prevention.

    Enteric-coated aspirin tablets are not recommended. There is no convincing evidence that at a daily dose of 75mg using enteric coated rather than soluble aspirin reduces the risk of gastrointestinal bleeding. (Ref: Drug Ter Bull. Jan 1997, p7-8).
    05.03.01 Atazanavir Reyataz®
    05.03.01 Atazanavir and Cobicistat Evotaz® Tablets
    02.04 Atenolol  Tablets
    Syrup
    Injection
    04.04 Atomoxetine  Mental health services only
    02.12 Atorvastatin 

    Tablets

    note 30mg and 60mg tablets are not to be prescribed

    07.01.03 Atosiban Tractocile® Not to be initiated at Pennine Acute Trust
    05.04.08 Atovaquone  Oral suspension
    15.01.05 Atracurium Besilate 
    15.01.03 Atropine 
    11.05 Atropine Sulphate  0.5% eye drops
    1% eye drops
    1% single-use eye drops (Minims®)

    13.02.01 Aveeno®  Cream

    Restricted Item Dermatology only
    24.03 Azacitadine SC Injection 
    01.05.03 Azathioprine  Tablets
    08.02.01 Azathioprine  Tablets
    Injection


    Red Traffic Light  Red if there is no shared care protocol (licensed indications only)

    10.01.03 Azathioprine  Tablets
    13.05.03 Azathioprine  Tablets

    unlicensedunlicensed indication (severe refractory eczema)
    05.01.05 Azithromycin  Capsules
    Tablets
    Oral Suspension
    11.03.01 Azithromycin Azyter®

    Eye drop solution in single-dose container

    For use in paediatric conjunctivitis - see policy

    05.01.02.03 Aztreonam  Injection

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    09.06.02 B Vitamins, High Potency Pabrinex® Intravenous Injection
    Intramuscular Injection
    10.02.02 Baclofen  Tablets
    Oral solution
    13.02.01.01 Balneum Plus Bath Oil 
    13.02.01 Balneum® Plus cream  Cream
    01.05.01 Balsalazide Sodium Colazide® Capsules

    Restricted Item Specialist initiation only
    24.02 BBraun Nutriflex Lipid Peri 1250  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Lipid Peri 1875  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Lipid Peri 2500  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Lipid Plus 2500  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Lipid Special 1250  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Lipid Special 1875  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Lipid Special 1875 EF  Additions of electrolytes available on request
    24.02 BBraun Nutriflex Special 1500  Additions of electrolytes available on request
    07.04.04 BCG (Bacillus Calmette-Guerin)  Bladder instillation
    08.02.04 BCG bladder instillation OncoTICE® Restricted Item Specialist use only
    14.04 BCG vaccine diagnostic agent Tuberculin PPD
    14.04 BCG vaccine Intradermal 
    03.02 Beclometasone Qvar® Metered Dose Inhaler (MDI)
    Easi-breathe®
    Autohaler®

    note Not licensed for use in paediatrics.
    03.02 Beclometasone Clenil Modulite® Metered Dose Inhaler (MDI)
    03.02 Beclometasone / formoterol / glycopyrronium Trimbow®

    Metered dose inhaler (MDI)

    Combination ICS/LABA/LAMA inhaler

    03.02 Beclometasone and formoterol Fostair® Metered dose inhaler (MDI)

    Combination ICS/LABA inhaler

    Fostair® contains an extra-fine formulation of beclomethasone and is more potent than traditional CFC-containing beclomethasone inhalers - check dose.

    note  First-line MDI for patients with COPD who cannot use dry powder inhalers or would prefer a metered-dose inhaler.
    12.02.01 Beclometasone Dipropionate  Nasal Spray
    05.01.09 Bedaquiline Sirturo® Tablets
    Restricted ItemCan only be prescribed after discussion with an ID physician
    03.04.02 Bee and Wasp Allergen Extracts Pharmalgen® Subcutaneous injection

    Restricted Item Specialist Use Only
    24.03 Bendamustine IV Infusion 
    02.02.01 Bendroflumethiazide  Tablets

    Not first line for hypertension (see NICE CG127: Hypertension). Patients with stable and controlled blood pressure currently taking bendroflumethiazide can continue treatment.

    12.03.01 Benzocaine  Anaesthetic gel
    13.06.01 Benzoyl Peroxide 2.5 - 10%  Gel
    Lotion
    13.06.01 Benzoyl Peroxide with antimicrobials Quinoderm® Cream
    12.03.01 Benzydamine Difflam® Mouthwash
    Oromucosal Spray
    05.01.01.01 Benzylpenicillin  Injection
    04.06 Betahistine  Tablets
    04.06 Betahistine Dihydrochloride 
    06.03.02 Betamethasone  Injection
    Soluble tablets
    11.04.01 Betamethasone   Eye/ear/nose drops
    Eye ointment
    13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic® Ointment
    Scalp Application
    13.04 Betamethasone (as Valerate) 0.025% Betnovate-RD® Cream
    Ointment
    13.04 Betamethasone (as Valerate) 0.1% Betnovate Scalp® Scalp application
    13.04 Betamethasone (as Valerate) 0.1% Non-proprietary or Betnovate® Cream
    Ointment
    13.04 Betamethasone (as Valerate) 0.1% with Clioquinol Non proprietary or Betnovate-C® Cream
    Ointment
    13.04 Betamethasone (as Valerate) 0.1% with Fucidic Acid 2% Fucibet® Cream
    13.04 Betamethasone (as Valerate) 0.1% with Neomycin Sulphate 0.5% Non-proprietary or Betnovate-N® Cream
    Ointment
    12.01.01 Betamethasone 0.1% with Neomycin 0.5% drops Betnesol N® Ear/eye/nose drops
    12.01.01 Betamethasone 0.1% with Neomycin 0.5% drops Betnesol N® Ear/eye/nose drops
    13.04 Betamethasone Dipropionate 0.064% with Clotrimazole 1% Lotriderm® Cream
    12.01.01 Betamethasone drops  Ear/eye/nose drops

    12.02.01 Betamethasone drops  Eye/ear/nose drops
    13.04 Betamethasone Valerate 0.1% Scalp Application Betacap® Scalp application
    11.04.01 Betamethasone with Neomycin  Eye/ear/nose drops
    11.06 Betaxolol  Eye drops
    Unit dose eye drops
    11.08.02 Bevacizumab intravitreal injection  Ocular injection

    Restricted Item Named-patient use only. For existing patients only. Ophthalmic consultant only

    unlicensedunlicensed
    08.03.04.02 Bicalutamide  Tablets
    11.06 Bimatoprost Lumigan® Eye drops
    Single-use eye drops
    11.06 Bimatoprost with Timolol Ganfort® Eye drops
    Single-use eye drops

    Combination products are licensed for once daily use where prostaglandin analogue alone is not adequate. Only use where patient has difficulty with compliance/administration.

    12.03.05 Biotene Oralbalance®  Saliva replacement gel
    09.08.01 Biotin   Tablets

    unlicensedunlicensed
    12.03.05 BioXtra®  Gel
    01.06.02 Bisacodyl  Tablets
    Suppositories
    02.04 Bisoprolol  Tablets
    24.03 Bleomycin IV Infusion 
    24.03 Bortezomib SC Injection 
    04.09.03 Botulinum Toxin Type A Botox®
    04.09.03 Botulinum Toxin Type A Dysport®
    24.03 Brentuximab IV Infusion 
    11.06 Brimonidine Tartrate Alphagan® Eye drops

    11.06 Brimonidine Tartrate 0.2% with Timolol 0.5% Combigan® Eye drops

    Combination products are licensed for use when beta blocker monotherapy does not provide adequate treatment. Only use where patient has difficulty with compliance/administration.

    11.06 Brinzolamide Azopt® Eye drops

    11.06 Brinzolamide 1% with Timolol 0.5%  Azarga® Eye drops

    Only use combination products where patient has difficulty with compliance/administration.
    06.07.01 Bromocriptine  Tablets
    Capsules

    01.05.02 Budesonide Entocort® C/R capsules

    Restricted Item Specialist initiation only: for treatment resistant terminal-ileal Crohn's disease
    03.02 Budesonide  Dry powder inhaler (Easyhaler®, Pulmicort® Turbohaler)
    Respules
    03.02 Budesonide and formoterol Symbicort® Turbohaler Dry powder inhaler

    Combination ICS/LABA inhaler

    Restricted Item Not to be initiated, but can be continued in established patients
    03.02 Budesonide and formoterol DuoResp® Spiromax Dry powder inhaler

    Combination ICS/LABA inhaler
    02.02.02 Bumetanide  Tablets
    Liquid

    Injection has been discontinued

    15.02 Bupivacaine and Adrenaline 
    15.02 Bupivacaine Hydrochloride 
    15.02 Bupivacaine with Fentanyl 
    04.07.02 Buprenorphine  Patches (BuTrans® or Transtec®)
    S/L tablets (Temgesic®)
    04.10.03 Buprenorphine Subutex® Sublingual tablets
    04.09.01 Cabergoline  Tablets
    06.07.01 Cabergoline  Tablets
    09.05.01.01 Cacit®  Effervescent tablets
    13.03 Calamine  Cream
    Lotion
    13.05.02 Calamine and Coal Tar Ointment  Ointment
    09.05.01.01 Calcichew®  Chewable tablets
    13.05.02 Calcipotriol  Ointment
    Scalp solution

    Restricted Item To be commenced on advice of dermatology only
    13.05.02 Calcipotriol 50micrograms/g with Betamethasone 0.05% Dovobet® Ointment
    Gel

    Restricted Item To be commenced on advice of dermatology only
    06.06.01 Calcitonin (salmon) / Salcatonin  Injection
    09.06.04 Calcitriol  Capsules

    For maintenance, not for treatment
    13.05.02 Calcitriol 3micrograms/g Silkis® Ointment

    Restricted Item To be commenced on advice of dermatology only
    09.05.02.02 Calcium Acetate Phosex® 1 gram tablets

    09.06.04 Calcium and colecalciferol Calfovit D3® Sachets
    09.06.04 Calcium and Colecalciferol Calceos® Chewable tablets
    09.05.02.02 Calcium Carbonate Calcichew® 500mg chewable tablets

    09.05.01.01 Calcium Chloride 10% Injection  Injection
    05.04.07 Calcium Folinate 
    05.04.07 Calcium Folinate  Tablets
    Injection
    08.01 Calcium Folinate  Tablets
    Injection
    09.05.01.01 Calcium Gluconate 10% Injection  Injection

    13.02.01 Calmurid®  Cream
    09.04 Calogen  Dose calculated by dietitian
    06.01.02.03 Canagliflozin Invokana® Tablets
    02.05.05.02 Candesartan  Tablets
    13.09 Capasal® Shampoo  Shampoo
    05.01.09 Capreomycin Capastat® Intramuscular Injection

    Restricted Item Can only be prescribed following discussion with an ID physician
    06.01.05 Capsaicin  Cream 0.075&
    10.03.02 Capsaicin  0.025% cream (adjunct in hand or knee osteoarthritis)
    0.075% cream (postherpetic neuralgia and diabetic neuropathy)
    02.05.05.01 Captopril  Tablets
    Oral solution unlicensedunlicensed. Restricted Item For paediatric use only

    Not as per GMMMG for adults
    04.02.03 Carbamazepine  Tablets
    M/R tablets
    Liquid
    Suppositories
    04.07.03 Carbamazepine  Tablets
    M/R tablets
    Liquid
    Suppositories
    04.08.01 Carbamazepine  Tablets
    M/R tablets
    Liquid
    Suppositories

    note Ensure patients are maintained on a specific manufacturer's product / brand
    06.02.02 Carbimazole  Tablets

    03.07 Carbocisteine  Capsules
    Liquid

    11.08.01 Carbomers  Eye drops
    Single-use eye drops

    Brand with lowest aquisition cost will be supplied.
    24.03 Carboplatin IV Infusion 
    07.01.01 Carboprost Hemabate® Injection
    24.03 Carfilzomib IV Infusion 
    11.08.01 Carmellose  Eye drops
    Single-use eye drops

    Brand with lowest aquisition cost will be supplied.
    12.03.01 Carmellose Sodium Orabase® Oral paste
    12.03.01 Carmellose Sodium Orahesive® Powder
    09.08.01 Carnitine Carnitor®
    11.06 Carteolol Teoptic® Eye drops
    02.04 Carvedilol  Tablets
    05.02.04 Caspofungin Cancidas® Intravenous Infusion

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    07.04.04 Catheter Patency Solutions Solution R Uro-Tainer®
    07.04.04 Catheter Patency Solutions Sodium Chloride 0.9% Uro-Tainer®
    13.02.02 Cavilon®Film  Barrier Preparation

    DotObtained through SUPPLIES not pharmacy
    13.09 Ceanel Concentrate® Shampoo  Shampoo
    05.01.02.01 Cefalexin  Capsules
    Tablets
    Oral Suspension
    05.01.02.01 Cefixime  Tablets
    Oral Suspension
    05.01.02.01 Cefotaxime  Injection
    05.01.02.01 Ceftazidime  Injection
    05.01.02.01 Ceftriaxone  Injection
    05.01.02.01 Cefuroxime Zinacef® Injection
    Tablets
    Oral Suspension
    11.03.01 Cefuroxime   Eye drops unlicensedunlicensed special

    STORE IN FREEZER PRIOR TO USE. Once thawed, store in fridge for a maximum of 7 days.
    10.01.01 Celecoxib Celebrex® Capsules
    10.01.03 Certolizumab Pegol  Subcutaneous Injection

    Supplied via homecare arrangements
    12.01.03 Cerumol®  Ear drops

    Not on GMMMG Formulary
    03.04.01 Cetirizine  Tablets
    Oral solution
    13.02.01 Cetraben®  Cream
    13.10.05 Cetrimide 0.5% Cream  Cream
    04.01.01 Chloral Hydrate 500mg in 5mL 
    05.01.07 Chloramphenicol  Injection
    (Oral preparations are non-formulary)
    11.03.01 Chloramphenicol  Eye drops
    Eye ointment
    Single use eye drops (Minims®)



    04.10.01 Chlordiazepoxide  Capsules
    11.03.01 Chlorhexidine  Eye drops unlicensedunlicensed special

    Restricted Item Used with propamidine for acanthamoeaba keratitis only
    12.03.04 Chlorhexidine Gluconate  Mouthwash
    Dental gel
    Oral spray
    12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin® Cream

    note Contains PEANUT oil
    05.04.01 Chloroquine  Tablets
    Syrup
    02.02.01 Chlorothiazide  Suspension

    unlicensedunlicensed


    Restricted Item Paediatric use only
    03.04.01 Chlorphenamine  Tablets
    Oral Solution
    04.02.01 Chlorpromazine  Tablets
    Oral solution
    Injection
    14.04 Cholera vaccine Dukoral® Restricted Item NMGH Travel Clinic only
    12.03.01 Choline Salicylate Bonjela® Adult Oral gel

    Restricted Item For over 16 years of age only
    06.05.01 Chorionic Gonadotrophin Pregnyl® Injection
    01.05.03 Ciclosporin  Capsules (Neoral®)
    Concentrate for intravenous infusion (Sandimmun®)

    MUST be prescribed by brand
    08.02.02 Ciclosporin  Capsules
    Oral solution

    note Prescribe by brand. Do not switch between brands.
    Brands:
  • Capimune®
  • Capsorin®
  • Deximune®
  • Neoral®


    Red Traffic Light  Red if no shared care protocol (licensed indications only)

  • 10.01.03 Ciclosporin  Capsules

    Prescribe by brand
    13.05.03 Ciclosporin  Capsules
    Oral Solution

    Must be prescribed by BRAND. (See Section 8.2.2.)
    05.03.02.02 Cidofovir Vistide®
    24.03 Cidofovir IV Infusion 
    07.03.01 Cilest®  Ethinylestradiol 35 mcg / norgestimate 250 mcg Standard strength preparation
    09.05.01.02 Cinacalcet Mimpara® Tablets

    Use is subject to a local shared-care agreement with the patient's GP (see link)
    04.06 Cinnarizine  Tablets
    04.06 Cinnarizine 
    05.01.12 Ciprofloxacin  Tablets
    Oral Suspension
    Intravenous Infusion: Restricted Item requires microbiology/ID consultant approval, unless use is in line with antibiotic policy
    11.03.01 Ciprofloxacin  Eye drops
    15.01.05 Cisatracurium Nimbex®
    24.03 Cisplatin IV Infusion 
    04.03.03 Citalopram  Tablets
    Oral drops
    24.03 Cladribine IV Infusion 
    24.03 Cladribine SC Injection 
    05.01.05 Clarithromycin  Tablets
    Oral Suspension
    Intravenous Infusion
    24.01 Clarithromycin IV Infusion  500mg in 250mL sodium chloride 0.9%
    05.01.06 Clindamycin  Capsules
    Injection
    05.04.07 Clindamycin  Capsules
    Injection
    05.04.08 Clindamycin  Capsules
    Injection
    07.02.02 Clindamycin  Cream
    13.06.01 Clindamycin 1% Dalacin T® Topical solution
    13.06.01 Clindamycin 1% Zindaclin® Gel
    04.08.01 Clobazam  Tablets
    Oral suspension
    13.04 Clobetasol Propionate 0.05% Dermovate® Cream
    Ointment
    Scalp Application
    13.04 Clobetasol Propionate 0.05% Etrivex® Shampoo

    Restricted Item Dermatology only
    13.04 Clobetasone Butyrate 0.05% Eumovate® Cream
    Ointment
    13.04 Clobetasone butyrate 0.05% with Oxytetracycline and Nystatin Trimovate® Cream
    24.03 Clofarabine SC Injection 
    05.01.10 Clofazimine  Capsules

    Restricted Item Can only be prescribed following discussion with an ID physician
    06.05.01 Clomifene Citrate  Tablets

    Restricted Item Only indicated for patients in whom ovulatory dysfunction has been demonstrated and other causes of infertility have been excluded or adequately treated
    04.03.01 Clomipramine  Capsules
    M/R tablets

    Included as first choice in the treatment of OCD only
    04.08.01 Clonazepam  Tablets
    Injection
    02.05.02 Clonidine Hydrochloride  Tablets
    02.09 Clopidogrel  Tablets

    See information above.
    07.02.02 Clotrimazole  Cream
    Pessary
    12.01.01 Clotrimazole Canesten® 1% solution
    13.10.02 Clotrimazole 1%   Cream
    Solution
    Spray
    04.02.01 Clozapine Clozaril® Clozapine is only indicated for treatment resistant schizophrenia.
    Prescribers, pharmacies and patients must be registered with the relevant supplier’s patient monitoring service.
    04.02.01 Clozapine Zaponex® Clozapine is only indicated for treatment resistant schizophrenia.
    Prescribers, pharmacies and patients must be registered with the relevant supplier’s patient monitoring service.
    13.05.02 Coal Tar 1% Lotion  Lotion
    13.05.02 Coal Tar and Salicylic Acid in Unguentum M 
    Restricted Item To be commenced on advice of dermatology only
    13.05.02 Coal Tar in Salicylic Acid Ointment  Ointment
    13.05.02 Coal Tar in Yellow Soft Paraffin  0.5%
    1%
    3%
    5%
    10%
    15%
    20%
    25%
    13.05.02 Coal Tar Paste  Paste
    02.02.04 Co-amilofruse (amiloride and furosemide)  Tablets
    Although it is preferable to prescribe potassium-sparing diuretics and loop diuretics separately, the use of fixed combinations may be justified if compliance is a problem (BNF).
    02.02.04 Co-amilozide  Tablets
    Although it is preferable to prescribe potassium-sparing diuretics and thiazide diuretics separately, the use of fixed combinations may be justified if compliance is a problem (BNF).
    05.01.01.03 Co-Amoxiclav  Tablets
    Oral Suspension
    Injection

    Restricted Item Co-amoxiclav is only recommended as first line treatment in specific indications. Refer to Antibiotic Policy.

    The risk of acute liver toxicity is 6 times greater with co-amoxiclav than with amoxicillin. Cholestatic jaundice is more common in patients above the age of 65 and in males. The duration of treatment should not normally exceed 14 days.

    Co-amoxiclav is a recognised cause of Clostridium difficile infections and its use should be restricted.
    04.09.01 Co-Beneldopa Madopar® Capsules
    Dispersible tablets
    M/R capsules
    05.03.01 Cobicistat Tybost® Tablets

    Requires MDT discussion with ID team
    11.07 Cocaine  Eye drops

    unlicensedunlicensed
    04.09.01 Co-Careldopa Sinemet® Tablets
    M/R tablets
    04.09.01 Co-Careldopa and Entacapone Stalevo® Tablets
    13.06.02 Co-Cyprindiol 2000/35
    (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
     Dianette®
    Tablets
    13.09 Co-Cyprindiol 2000/35
    (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
     Dianette®
    Tablets
    01.06.02 Co-danthramer  Capsules
    Strong capsules
    Suspension
    Strong suspension

    Restricted Item Specialist use: Palliative care only
    01.06.02 Co-danthrusate  Capsules
    Suspension

    Restricted Item Specialist use: Palliative care only
    01.04.02 Codeine  Tablets
    Oral solution
    03.09.01 Codeine Linctus BP  Oral solution

    04.07.02 Codeine Phosphate  Tablets
    Oral liquid
    10.01.04 Colchicine  Tablets
    09.06.04 Colecalciferol  Capsules
    Oral solution

    09.06.04 Colecalciferol and Calcium Carbonate Calcichew-D3® Chewable tablets
    09.06.04 Colecalciferol and Calcium Carbonate Calcichew-D3® Forte Chewable tablets
    09.06.04 Colecalciferol and Calcium Carbonate Adcal-D3® Chewable Tablets
    Caplets
    Effervescent Tablets

    01.09.02 Colestyramine Questran Light®
    02.12 Colestyramine  Powder
    05.01.07 Colistimethate  Intravenous injection
    Injection for nebulisation (Colomycin® brand)
    Powder for nebuliser solution

    GMMMG RAG status when nebulised:

    Red Traffic Light  RED for cystic fibrosis patients

    Amber Traffic Light  AMBER for non-cystic fibrosis patients

    10.03.01 Collagenase Xiapex® Intralesional injection

    Individual funding request is NOT required when used for Dupytren's contracture that is moderate in nature. Defined as:

  • Notable functional problems,
    AND one of the following:
  • Moderate metacarpo-phalangeal joint contracture (30° – 60°)
    OR
  • Moderate proximal inter-phalangeal joint contracture (<30°)
    OR
    First web contracture.

    For all other indications (e.g. Frozen Shoulder / Peyronie's Disease / any other use / non-moderate Dupytren's) an individual funding request is required.
  • 01.01.01 Co-magaldrox suspension 
    09.02.02.01 Compound Sodium Lactate Intravenous Infusion  500ml bag
    1 litre bag
    13.02.02 Conotrane®  Cream
    05.01.08 Co-trimoxazole  Tablets
    Oral Suspension
    Intravenous Infusion

    05.04.08 Co-trimoxazole  See section 5.1.8.
    13.03 Crotamiton Eurax® Cream
    Lotion
    13.11.06 Crystacide® Hydrogen Peroxide 1% Cream
    13.11.02 CX Antiseptic Dusting Powder® Chlorhexidine
    09.01.02 Cyanocobalamin  Tablets

    Only for use in those patients who are truly unable to tolerate injections and who are vegan or have a proven dietary deficiency.
    04.06 Cyclizine  Tablets
    Injection
    04.06 Cyclizine  Tablets
    Injection
    04.06 Cyclizine  Tablets
    Injection
    04.06 Cyclizine  Tablets
    Injection
    04.06 Cyclizine  Tablets
    Injection
    11.05 Cyclopentolate Hydrochloride  0.5% and 1% eye drops
    0.5% and 1% single-use eye drops (Minims®)
    10.01.03 Cyclophosphamide  Tablets
    Injection
    24.03 Cyclophosphamide IV Infusion 
    24.03 Cyclophosphamide IV Injection 
    24.03 Cyclophosphamide, Etoposide and Cisplatin IV Infusion 
    05.01.09 Cycloserine  Capsules

    Restricted Item Can only be prescribed following discussion with an ID physician
    06.04.02 Cyproterone Acetate  Tablets
    08.03.04.02 Cyproterone Acetate  Tablets


    Green Traffic Light  Following specialist initiation

    24.03 Cytarabine Intrathecal Injection 
    24.03 Cytarabine IV Infusion 
    24.03 Cytarabine IV Injection 
    24.03 Cytarabine SC Injection 
    02.08.02 Dabigatran Pradaxa® Capsules

    Praxbind® (idarucizumab) is a specific reversal agent for dabigatran. This may be used on the advice of a haematologist only - see PAT guideline: Management of Bleeding in Patients Receiving Anti-thrombotic Agents.
    02.08.02 Dabigatran Pradaxa® Capsules

    Praxbind® (idarucizumab) is a specific reversal agent for dabigatran. This may be used on the advice of a haematologist only - see PAT guideline: Management of Bleeding in Patients Receiving Anti-thrombotic Agents.
    02.08.02 Dabigatran Pradaxa® Capsules

    Praxbind® (idarucizumab) is a specific reversal agent for dabigatran. This may be used on the advice of a haematologist only - see PAT guideline: Management of Bleeding in Patients Receiving Anti-thrombotic Agents.
    24.03 Dacarbazine IV Infusion 
    05.03.03.02 Daclatasvir Daklinza® Tablets

    Restricted Item  Requires MDT discussion with ID team
    02.08.01 Danaparoid Orgaran® Injection

    Restricted Item For prevention and treatment of thromboembolic disease in patients with a history of heparin-induced thrombocytopenia.
    06.07.02 Danazol  Capsules
    10.02.02 Dantrolene  Capsules
    15.01.08 Dantrolene Sodium Dantrium Intravenous®
    06.01.02.03 Dapagliflozin  Tablets

    05.01.10 Dapsone  Tablets
    05.04.08 Dapsone  Tablets
    05.01.07 Daptomycin  Intravenous Infusion
    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    24.03 Daratumumab IV Infusion 
    09.01.03 Darbepoetin Alfa Aranesp® Injection
    05.03.01 Darunavir Prezista®
    05.03.01 Darunavir and Cobicistat Rezolsta® Tablets
    05.03.03.02 Dasabuvir Exviera® Tablets

    Restricted Item Requires MDT discussion with ID team
    24.03 Daunorubicin IV Infusion 
    24.03 Daunorubicin liposomal IV Infusion 
    09.01.03 Deferasirox Exjade® Dispersible tablets

    PbR Excluded - commissioned by NHS England
    09.01.03 Deferiprone Ferriprox® Tablets

    PbR Excluded - commissioned by NHS England
    05.01.09 Delamanid Deltyba® Tablets
    Restricted ItemCan only be prescribed following discussion with an ID physician
    06.05.02 Demeclocycline  Capsules

    note See section 6.5.2 of BNF for details of dosage in SIADH unlicensedunlicensed
    06.06.02 Denosumab Prolia® Injection

    06.06.02 Denosumab XGEVA® Injection
    13.02.01 Dermol®  Cream
    Dermol 500 Lotion
    13.02.01.01 Dermol® 
    13.02.01.01 Dermol® 600 bath emollient 
    09.01.03 Desferrioxamine Mesilate  Injection

    PbR Excluded- commissioned by NHS England
    15.01.02 Desflurane Suprane®
    06.05.02 Desmopressin  Tablets
    Sublingual tablets
    Nasal Spray
    Injection
    04.06 Dexamethasone  Tablets
    Oral solution
    Injection
    06.03.02 Dexamethasone  Tablets
    Injection
    Oral solution
    10.01.02.02 Dexamethasone  Injection
    11.04.01 Dexamethasone   Eye drops
    Single use eye drops (Minims®)

    11.04.01 Dexamethasone intravitreal implant Ozurdex® Intravitreal injection

    Restricted Item Specialist use only
    12.01.01 Dexamethasone with Antibacterial Otomize® Ear Spray
    12.01.01 Dexamethasone with Antibacterial Sofradex® Eye/ear drops

    Not on GMMMG formulary
    11.04.01 Dexamethasone with Antibacterials Sofradex® Eye/ear drops
    11.04.01 Dexamethasone with Neomycin and Polymyxin B sulphate Maxitrol® Eye drops
    Eye ointment
    04.04 Dexamfetamine 
    08.01 Dexrazoxane Savene® Intravenous Infusion
    04.07.02 Diamorphine  Injection
    04.01.02 Diazepam  Tablets
    Oral solution
    Injection
    Rectal tubes
    04.08.02 Diazepam   Injection (emulsion)
    Rectal tubes (rectal solution)

    note Use diazepam injection as first-line alternative only if lorazepam injection not available

    10.02.02 Diazepam  Tablets
    Oral solution
    15.01.04.01 Diazepam 
    10.01.01 Diclofenac  Suppositories
    Injection


    Restricted Item Diclofenac is contraindicated in patients with established:

    •ischaemic heart disease
    •peripheral arterial disease
    •cerebrovascular disease
    •congestive heart failure (New York Heart Association [NYHA] classification II–IV)

    Diclofenac treatment should only be initiated after careful consideration for patients with significant risk factors for cardiovascular events (eg, hypertension, hyperlipidaemia, diabetes mellitus, smoking).

    11.08.02 Diclofenac Voltarol® Ophtha Eye drops
    Single use eye drops

    (Not on GMMMG formulary)
    05.03.01 Didanosine Videx® Tablets
    Capsules

    Restricted Item Only for patients already established on this treatment.
    05.05.06 Diethylcarbamazine  Tablets

    unlicensedunlicensed


    08.03.01 Diethylstilbestrol  Tablets


    02.01.01 Digoxin 
  • Tablets
  • Liquid
  • Injection

  • When switching from oral to intravenous digoxin, the intravenous dose should be approximately 70% of the oral dose.

    GMMMG does not recommend digoxin as first-line for rate control of atrial fibrillation in ambulant patients.

    For plasma concentration monitoring, blood should be taken at least 6 hours after a dose.

    02.01.01 Digoxin specific antibody fragments Digifab® See link for SPC
    04.07.02 Dihydrocodeine  Tablets
    M/R tablets
    05.04.02 Diloxanide Furoate  Tablets
    02.06.02 Diltiazem  Standard tablets (60mg)
    Modified release tablets
    Modified release capsules

    Specify the brand when prescribing a diltiazem preparation (except for 60mg tablet).

    01.07.04 Diltiazem Cream 2% 
    13.05.02 Dimethyl fumarate Skilarence® Tablets

    Restricted Item Dermatology only
    07.04.04 Dimethyl Sulfoxide 50% Rimso-50® Bladder instillation
    13.10.04 Dimeticone Hedrin® Lotion
    07.01.01 Dinoprostone  Pessaries (Propess®)
    Vaginal Tablets (Prostin E2®)
    14.04 Diphtheria antitoxin  Microbiology / ID recommendation only
    14.04 Diphtheria with Hib, pertussis, poliomyelitis and tetanus  Pediacel®
    14.04 Diphtheria with Hib, pertussis, poliomyelitis and tetanus Infanrix-IPV + Hib®
    14.04 Diphtheria with pertussis, poliomyelitis and tetanus Repevax®
    14.04 Diphtheria with poliomyelitis and tetanus Revaxis®
    13.02.01 Diprobase®  Cream
    Ointment
    02.09 Dipyridamole  Tablets
    Modified Release Capsules
    Oral suspension

    See information above.
    02.09 Dipyridamole and Aspirin Asasantin® Retard Modified release capsules.

    See information above.
    11.99.99.99 Disodium Edetate 0.37%   Eye lotion
    06.06.02 Disodium Pamidronate  Concentrate for Intravenous Infusion

    note Refer to Electrolyte Disturbances Guidelines for dosage in hypercalcaemia
    02.03.02 Disopyramide  Capsules
    (Injection discontinued)

    04.10.01 Disulfiram Antabuse® Restricted Item Specialist initiation only
    13.05.02 Dithranol Dithrocream® Cream: 0.1%, 0.25%, 0.5%, 1%, 2%.

    13.05.02 Dithranol in Zinc and Salicylic Acid in Lassar's Paste Paste

    unlicensedunlicensed
    02.07.01 Dobutamine  Concentrate for intravenous infusion (dilute before use).

    01.06.02 Docusate Sodium  Capsules
    Oral suspension
    05.03.01 Dolutegravir Tivicay ® Tablets
    05.03.01 Dolutegravir and Abacavir and Lamivudine Triumeq ®
    01.02 Domperidone  Tablets
    Suspension

    unlicensedunlicensed indication

    note Studies have shown that domperidone may be associated with a small increased risk of serious cardiac side effects.
    DotThese risks may be higher in patients older than 60 years and in patients who receive daily oral doses of more than 30 mg.
    DotDomperidone should be used at the lowest effective dose for the shortest possible time
    DotMaximum treatment duration should not exceed one week
    DotDomperidone is contra-indicated in patients who are taking concomitant medication known to cause QT prolongation (such as ketoconazole and erythromycin)
    04.06 Domperidone  Tablets
    Suspension
    unlicensedSuppositories (unlicensed)
    04.11 Donepezil  Tablets
    Orodispersible tablets

    Green Traffic Light Commissioning arrangements may vary and in some localities this is Green2 - check with relevant CCG
    02.07.01 Dopamine  Concentrate for intravenous infusion (dilute before use).
    02.07.01 Dopexamine  Concentrate for intravenous infusion (dilute before use).
    03.07 Dornase Alfa Pulmozyme® nebuliser solution

    Restricted Item Must only be initiated within hospital for the treatment of cystic fibrosis.
    11.06 Dorzolomide  Eye drops
    Unit dose eye drops

    11.06 Dorzolomide 2% with Timolol 0.5%  Eye drops
    Unit dose eye drops

    Only use combination products when patient has difficulty with compliance/administration.

    13.02.01 DoubleBase®  Gel
    03.05.01 Doxapram  Intravenous injection

    May also be given by intravenous infusion (unlicensed)
    02.05.04 Doxazosin  Tablets

    Doxazosin is a fourth-line hypertension management option.

    note Modified release preparations of doxazosin are not approved by GMMMG. Consider converting any existing patients to standard release doxazosin, using the UKMi Medicines Q&A for guidance.
    07.04.01 Doxazosin  Tablets
    07.04.04 Doxorubicin  Bladder instillation

    note Liaise with Pharmacy Aseptics for preparation of this product
    24.03 Doxorubicin IV Infusion 
    24.03 Doxorubicin IV Injection 
    05.01.03 Doxycycline  Capsules
    Dispersible Tablets
    05.04.01 Doxycycline  See section 5.1.3.
    13.06.02 Doxycycline  Capsules

    Alternative choice for acne and rosacea
    13.02.02 Drapolene®  Cream
    02.03.02 Dronedarone Multaq® Tablets

    Restricted Item  Cardiologist/stroke physician initiation only

    Dronedarone should only be initiated as a second line treatment option for non-permanent atrial fibrillation after:
  • standard NICE first line options are either cautioned/contraindicated or have failed
  • and if
  • amiodarone use is cautioned/intolerated
  • It should only be used in clinically stable patients, and is not recommended for those with NYHA Class III/IV heart failure.

    Dronedarone is not recommended for patients with permanent AF.

    See attached guidance for more information.
    03.01.05 Drug Delivery Device Volumatic®
    03.01.05 Drug Delivery Device AeroChamber Plus®
    04.03.04 Duloxetine Cymbalta®
    04.07.03 Duloxetine Cymbalta® Capsules

    noteDuloxetine may be considered as an option where other treatments have failed, or for a clear diagnosis of diabetic neuropathy.
    06.01.05 Duloxetine Cymbalta® Capsules

    07.04.02 Duloxetine Yentreve® Capsules

    For stress incontinence only
    13.08.01 Dundee reflective sun creams Dundee Block® Restricted Item Dermatology Only

    unlicensedunlicensed
    06.04.02 Dutasteride Avodart® Tablets
    13.08.01 E45 Sun Reflective Sunscreen® 
    Preparations with an SPF less than 30 should not be prescribed.

    13.02.01 E45® Cream  Cream
    07.02.02 Econazole  Cream
    02.08.02 Edoxaban Lixiana® Tablets
    02.08.02 Edoxaban Lixiana® Tablets
    05.03.01 Efavirenz Sustiva®
    13.09 Eflornithine 11.5% Cream Vaniqa®
    Restricted Item  Dermatology only
    05.03.03.02 Elbasvir/Grazoprevir Zepatier® 50mg/100mg Tablets

    Restricted Item Requires MDT discussion with ID team
    06.04.01.01 Elleste Duet®  Tablets

    Estradiol 1mg + norethisterone 1mg
    Estradiol 2mg + norethisterone 1mg


    06.04.01.01 Elleste-Solo®  Tablets

    Estradiol 1mg
    Estradiol 2mg

    09.01.04 Eltrombopag Revolade® Tablets

    PbR Excluded - commissioned by CCG
    05.03.01 Emtricitabine Emtriva®
    05.03.01 Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera®
    13.02.01.01 Emulsiderm® Liquid Emulsion 
    13.02.01 Emulsifying Ointment BP  Ointment
    02.05.05.01 Enalapril   Tablets

    09.04 Enfamil AR  Dose dependent on age
    09.04 Enfamil olac  Dose dependent on age
    05.03.01 Enfuvirtide Fuzeon®
    02.08.01 Enoxaparin  Subcutaneous injection

    Green Traffic Light Green2 or Green3 depending on indication. See GMMMG RAG list for full details
    02.01.02 Enoximone Perfan® Intravenous Injection
    09.04 Enshake  Vanilla
    Chocolate
    Strawberry
    Banana
    09.04 Ensure Compact 125ML  Vanilla
    Strawberry
    Banana
    09.04 Ensure Plus Bottles 220ML  Chocolate
    Strawberry
    Coffee
    Vanilla
    Raspberry
    Banana
    Orange
    Fruits of Forest
    Neutral
    Peach
    09.04 Ensure Plus Creme  Vanilla
    Neutral
    Chocolate
    Banana
    09.04 Ensure Plus Fibre 200ML  Vanilla
    Chocolate
    Raspberry
    Banana
    Strawberry
    09.04 Ensure Plus Juce 220ML  Strawberry
    Fruit Punch
    Lemon & Lime
    Orange
    Peach
    Apple
    09.04 Ensure Plus Yoghurt Style 220ML  Strawberry Swirl
    Orchard Peach
    09.04 Ensure Twocal 200ML  Banana
    vanilla
    Neutral
    Strawberry
    04.09.01 Entacapone 
    05.03.03.01 Entecavir Baraclude®
    15.01.02 Entonox® 
    13.02.01 Epaderm®  Cream
    Ointment
    02.07.02 Ephedrine  Intravenous injection
    12.02.02 Ephedrine  Nasal drops

    Restricted Item Licensed for over 12 years of age only
    07.04.04 Epirubicin  Bladder instillation

    note Liaise with Pharmacy Aseptics for preparation of this product
    24.03 Epirubicin IV Injection 
    02.02.03 Eplerenone  Tablets

    09.01.03 Epoetin alfa Eprex® Injection
    09.01.03 Epoetin beta NeoRecormon® Injection
    02.08.01 Epoprostenol Flolan® Infusion
    02.09 Eptifibatide Integrilin® Injection
    Infusion

    09.06.04 Ergocalciferol  Oral solution
    IM injection
    07.01.01 Ergometrine Maleate  Injection
    07.01.01 Ergometrine Maleate and Oxytocin Syntometrine® Injection
    05.01.02.02 Ertapenem  Intravenous Infusion

    Restricted Item Not for inpatient use
    01.02 Erythromycin  Tablets
    Oral Suspension
    Intravenous infusion

    unlicensedunlicensed indication
    05.01.05 Erythromycin  Capsules
    Tablets
    Oral Suspension
    Intravenous Infusion
    11.03.01 Erythromycin  Eye ointment unlicensedunlicensed special
    13.06.02 Erythromycin  Tablets

    First choice for rosacea. Alternative to oxytetracycline for acne.
    13.06.01 Erythromycin 2%  Stiemycin® Topical solution
    13.06.01 Erythromycin 40mg with Zinc Acetate 12mg/mL Zineryt® Topical solution
    04.03.03 Escitalopram  Tablets
    Oral drops
    02.04 Esmolol  Intravenous Infusion

    Restricted Item Cardiologist/anaesthetist initiation only
    10.01.03 Etanercept Enbrel® Subcutaneous Injection

    Supplied via homecare arrangements

    10.01.03 Etanercept Benepali® Subcutaneous Injection

    Supplied via homecare arrangements

  • New patients only

  • 13.05.03 Etanercept Enbrel®
    05.01.09 Ethambutol   Tablets
    02.13 Ethanolamine Oleate  Injection
    08.03.01 Ethinylestradiol  Tablets
    04.08.01 Ethosuximide  Capsules
    Syrup
    10.01.01 Etodolac  Capsules
    Modified release tablets
    15.01.01 Etomidate Etomidate-Lipuro®
    15.01.01 Etomidate Hypnomidate®
    07.03.02.02 Etonorgestrel Nexplanon® Implant
    24.03 Etoposide IV Infusion 
    24.03 Etoposide, Doxorubicin and Vincristine IV Infusion 
    10.01.01 Etoricoxib Arcoxia® Tablets
    05.03.01 Etravirine Intelence®
    02.12 Evolocumab Repatha® Pre-filled syringe
    Pre-filled pen
    Only as per NICE TA394.
    Requires completion of Blueteq form prior to initiation.
    Available via Homecare providers.

    06.04.01.01 Evorel Conti®  Patches

    Estradiol 50micrograms/24hours + norethisterone 170micrograms/24hours
    06.04.01.01 Evorel Sequi®   Patches

    Estradiol 50micrograms
    plus
    Estradiol 50micrograms + norethisterone acetate 170micrograms
    06.04.01.01 Evorel®  Patches

    Estradiol 25, 50, 75, 100micrograms
    08.03.04.01 Exemestane  Tablets

    06.01.02.03 Exenatide Byetta® Disposable pen
    06.01.02.03 Exenatide Prolonged Release Bydureon® Vial

    Once weekly preparation
    02.12 Ezetimibe Ezetrol® Tablets

    Not licensed for primary or secondary prevention of cardiovascular disease.
    10.01.04 Febuxostat Adenuric® Tablets


    06.04.01.01 Femoston Conti®  Tablets

    Estradiol 1mg + dydrogesterone 5mg


    06.04.01.01 Femoston®  Tablets

    Estradiol 1mg + dydrogesterone 10mg
    Estradiol 2mg + dydrogesterone 10mg


    02.12 Fenofibrate  Capsules
    Tablets

    Fenofibrate has similar efficacy to bezafibrate in the reduction of triglycerides and is more potent in terms of LDL reduction and HDL elevation.

    04.07.02 Fentanyl  Patches
    Restricted Item Buccal tablets (Effentora®) Palliative care only
    Restricted Item Nasal spray (PecFent®) Palliative care only
    15.01.04.03 Fentanyl 
    09.01.01.02 Ferric Carboxymaltose Ferinject® Injection
    09.01.01.01 Ferric Maltol Feraccru® 30mg iron per capsule

    Restricted Item Consultant gastroenterologist only

    Alternative to IV iron in IBD patients intolerant to existing oral iron products, as per GMMMMG recommendations
    09.01.01.01 Ferrous Fumarate   45mg iron per 5ml
    09.01.01.01 Ferrous Fumarate   68mg iron per tablet
    09.01.01.01 Ferrous Fumarate   100mg iron per tablet
    09.01.01.01 Ferrous Sulphate  65mg iron per tablet
    07.04.02 Fesoterodine  M/R Tablets
    03.04.01 Fexofenadine  Tablets

    Restricted Item  For established patients only
    05.01.07 Fidaxomicin Dificlir® Tablets

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    09.01.06 Filgrastim Zarzio® Injection
    06.04.02 Finasteride  Tablets
    02.03.02 Flecainide  Tablets
    Injection

    Restricted Item Specialist initiation only.

    Restricted Item Paediatric Use: Specialist initiation and secondary care management until stable.
    05.01.01.02 Flucloxacillin  Capsules
    Oral Solution
    Injection
    24.01 Flucloxacillin IV Syringe  500mg/10mL
    1000mg/20mL
    2000mg/40mL
    05.02.01 Fluconazole  Capsules
    Oral Suspension
    Intravenous Infusion
    07.02.02 Fluconazole  Capsule
    12.03.02 Fluconazole  Capsules
    05.02.05 Flucytosine Ancotil® Intravenous Infusion

    Restricted Item ID consultant initiation only
    24.01 Flucytosine IV Infusion 
    24.03 Fludarabine IV Infusion 
    06.03.01 Fludrocortisone Acetate Florinef® Tablets
    13.04 Fludroxycortide  Haelan® Cream
    Ointment
    Tape (for chronic localised recalcitrant dermatoses, but not acute or weeping)
    12.01.01 Flumetasone 0.02% with Clioquinol 1% Locorten-Vioform® Ear drops

    12.01.01 Flumetasone 0.02% with Clioquinol 1% Locorten-Vioform® Ear drops

    13.04 Fluocinolone Acetonide 0.0025% Synalar 1 in 10 Dilution® Cream
    13.04 Fluocinolone Acetonide 0.00625% Synalar 1 in 4 Dilution® Cream
    Ointment
    13.04 Fluocinolone Acetonide 0.025% Synalar® Cream
    Gel
    Ointment
    13.04 Fluocinolone Acetonide 0.025% with Clioquinol 3% Synalar C® Cream
    Ointment
    13.04 Fluocinolone Acetonide 0.025% with Neomycin Sulphate 0.5% Synalar N® Cream
    Ointment
    11.04.01 Fluocinolone intravitreal implant Iluvien® Intravitreal implant

    Restricted Item Specialist use only
    13.04 Fluocinonide 0.05% Metosyn® FAPG cream

    Restricted Item Dermatology only
    11.08.02 Fluorescein Sodium Minims® Single-use eye drops

    Also available with local anaesthetic - see section 11.7
    11.04.01 Fluorometholone FML® Eye drops

    Intra-ocular penetration is poor. It may be considered useful in a few patients with chronic low grade uveitis where raised intra-ocular pressure has been problematic.
    11.99.99.99 Fluorouracil  Subconjunctival injection

    Prepared by pharmacy aseptics unit for named-patient use.
    13.08.01 Fluorouracil 0.5%, Salicylic Acid 10% Actikerall® Solution

    Restricted Item Dermatology only
    24.03 Fluorouracil Ophthalmic 
    04.03.03 Fluoxetine  Capsules
    Liquid
    04.02.01 Flupentixol  Tablets
    04.03.04 Flupentixol 
    04.02.02 Flupentixol Decanoate Depixol®
    04.02.02 Fluphenazine Decanoate Modecate®
    03.02 Fluticasone  Metered dose inhaler (Flixotide® Evohaler)
    Dry powder inhaler (Flixotide® Accuhaler)
    Nebules
    03.02 Fluticasone / umeclidinium / vilanterol Trelegy Ellipta®

    Dry powder inhaler (DPI)

    Combination ICS/LABA/LAMA inhaler

    03.02 Fluticasone and formoterol Flutiform® Metered dose inhaler

    Combination ICS/LABA inhaler

    note Licensed for ASTHMA only.
    03.02 Fluticasone and salmeterol Seretide® Metered dose inhaler (Seretide® Evohaler)
    Dry powder inhaler (Seretide® Accuhaler)

    Combination ICS/LABA inhaler

    note Only the Seretide 500 Accuhaler is licensed for use in COPD. Seretide 250 Evohaler is very expensive - please consider alternatives where possible.

    Restricted Item Not to be initiated, but can be continued in established patients.
    03.02 Fluticasone furoate & vilanterol Relvar Ellipta® Dry powder inhaler

    Combination ICS/LABA inhaler

    note184/22 strength licensed for ASTHMA only
    12.02.01 Fluticasone Propionate  50mcg/metered dose Nasal Spray
    04.03.03 Fluvoxamine Maleate  Tablets
    09.01.02 Folic Acid  Tablets
    Oral syrup
    Injection unlicensed(unlicensed)
    02.08.01 Fondaparinux Arixtra® Subcutaneous injection
    Green Traffic Light Depends on indication - see GMMMG website for further details
    Restricted Item Approved for prevention of venous thromboembolic events in orthopaedic surgery. Awaiting Trust-approved protocols for other indications.
    09.06.07 Forceval®  Capsules
    Soluble Tablets
    03.01.01.01 Formoterol   Dry powder inhaler 12 micrograms/dose (Easyhaler®)
    Dry powder inhaler 6 micrograms/dose, 12 micrograms/dose (Oxis® Turbohaler)

    05.03.01 Fosamprenavir Telzir®
    24.03 Foscarnet IV Infusion 
    05.03.02.02 Foscarnet Sodium Foscavir®
    05.01.13 Fosfomycin  Granules for oral suspension
    Injection

    Restricted Item Injection - Microbiology / ID recommendation only; for the treatment of carbapenemase-producing enterobacteriaceae

    08.03.04.01 Fulvestrant Faslodex® Intramuscular injection


    Red Traffic Light  Red for new patients. Not recommended by NICE.

    02.02.02 Furosemide  Tablets
    Liquid
    Injection

    11.03.01 Fusidic Acid  Eye drops
    13.10.01.02 Fusidic Acid 2% Fucidin® Cream
    Ointment
    04.07.03 Gabapentin  Capsules
    Oral solution
    04.07.03 Gabapentin  Capsules
    Oral solution
    04.08.01 Gabapentin  Capsules
    Oral solution
    06.01.05 Gabapentin  Capsules
    Oral solution
    04.11 Galantamine  Tablets
    M/R capsules
    Oral solution

    Green Traffic Light Commissioning arrangements may vary and in some localities this is Green2 - check with relevant CCG
    05.03.02.02 Ganciclovir Cymevene®


    Prepared by pharmacy aseptics during working hours. Liaise with pharmacy.
    11.03.03 Ganciclovir   Eye gel
    Restricted Item Specialist ophthalmologist only
    24.03 Ganciclovir IV Infusion 
    24.03 Ganciclovir IV Infusion 
    01.01.02 Gaviscon Advance  Suspension
    Chewable tablets
    01.01.02 Gaviscon Infant  Oral powder
    09.02.02.02 Gelatin Gelofusine® May be supplied as an alternative to Gelaspan if unavailable
    09.02.02.02 Gelatin Gelaspan®
    12.03.01 Gelclair®  Sachets
    24.03 Gemcitabine IV Infusion 
    07.01.01 Gemeprost  Pessaries
    24.03 Gemtuzumab IV Infusion 
    05.01.04 Gentamicin  Injection
    11.03.01 Gentamicin Genticin® 0.3% eye/ear drops
    1.5% eye drops unlicensedunlicensed special
    12.01.01 Gentamicin Genticin® Ear/eye drops

    Not on GMMMG formulary
    12.03.05 Glandosane®  Aerosol spray
    06.01.02.01 Gliclazide  Tablets
    06.01.02.01 Glimepiride  Tablets
    06.01.02.01 Glipizide  Tablets
    06.01.04 Glucagon GlucaGen® HypoKit
    06.01.04 GlucoGel® 
    09.02.02.01 Glucose 10% Intravenous  500ml bag
    1L bag
    09.02.02.01 Glucose 15% Intravenous  500ml bag
    09.02.02.01 Glucose 20% Intravenous  500ml bag
    09.02.02.01 Glucose 5% Intravenous  50ml bag
    100ml bag
    250ml bag
    500ml bag
    500ml Polyfusor
    1L bag
    09.02.02.01 Glucose 50% Intravenous  20ml amps
    50ml vial
    500ml bag
    01.06.02 Glycerol (Glycerin)  Suppositories (1st line for rectal use)
    02.06.01 Glyceryl Trinitrate  Spray
    Sublingual Tablets
    Patches
    Injection

    01.07.04 Glyceryl Trinitrate 0.4% Ointment Rectogesic®
    07.04.04 Glycine 1.5%  Bladder irrigation solution
    03.01.02 Glycopyrronium Seebri breezhaler® Inhalation powder, hard capsule for use with Breezhaler® device

    Reserved for COPD patients with intolerance to tiotropium, or those who cannot use tiotropium devices.
    15.01.03 Glycopyrronium 
    03.01.04 Glycopyrronium / Indacaterol Ultibro® Breezhaler Combination LABA/LAMA inhaler
    13.12 Glycopyrronium bromide  Restricted Item Dermatology only
    10.01.03 Golimumab  Subcutaneous Injection

    Supplied via homecare arrangements
    06.07.02 Goserelin  Intradermal implant 3.6mg (every 28 days)

    note  For use in breast and prostate cancer, see sections 8.3.4.1 and 8.3.4.2.

    "Amber" for licensed indications, "Red" for all unlicensed uses.
    08.03.04.02 Goserelin Zoladex® Zoladex® implant
    Zoladex®LA implant

    Amber Traffic Light  For licensed indications


    02.05.03 Guanethidine Monosulphate Ismelin® Intramuscular injection

    Restricted Item Licensed for rapid control of blood pressure, however alternative agents are preferred (BNF).

    04.04 Guanfacine Intuniv® Prolonged-release tablets
    14.04 Haemophilus influenzae type B Combined Vaccine Menitorix®
    04.02.01 Haloperidol  Tablets
    Capsules
    Oral liquid
    Injection
    04.02.02 Haloperidol Haldol Decanoate®
    04.06 Haloperidol  Tablets
    Capsules
    Oral liquid
    Injection
    02.08.01 Heparin  Injection

    02.08.01 Heparin  Flush solution

    note For maintaining patency of peripheral venous catheters, sodium chloride injection 0.9% is as effective as heparin flushes. The role of heparin flushes in maintaining patency of arterial and central venous catheters is unclear (BNF).

    All flush solutions must be prescribed. See NPSA Rapid Response Alert.
    24.01 Heparin 50 units in 50mL 0.18% sodium chloride 
    13.13 Heparinoid 0.3% Hirudoid® Cream
    14.04 Hepatitis A vaccine Single Component Havrix®
    14.04 Hepatitis A vaccine with Hepatitis B vaccine  Twinrix®
    14.04 Hepatitis A vaccine with typhoid vaccine Hepatyrix®
    14.04 Hepatitis A vaccine with typhoid vaccine VIATIM®
    14.05.02 Hepatitis B immunoglobulin  Medical team to contact Clinical Virology at Central Manchester Foundation Trust (0161 276 8853)
    14.04 Hepatitis B vaccine Single Component Engerix B®
    14.04 Hepatitis B vaccine Single Component Fendrix®

    Approved by Medical D&T on 26/3/15 for use after failure of previous vaccination course, as per BHIVA guidelines.
    14.04 Hepatitis B vaccine Single Component HBvaxPRO®
    13.11.02 Hibiscrub® Chlorhexidine
    13.11.02 Hibitane Obstetric®  Cream
    06.01.01.01 Humalog® Insulin Lispro 3ml cartridge (via Autopen® Classic or HumaPen®)
    3ml prefilled disposable pen (Kwikpen®)
    06.01.01.02 Humalog® Mix25 Biphasic Insulin Lispro 3ml cartridge (via Humapen® Luxura device)
    3ml prefilled disposable pen (Kwikpen® )

    06.01.01.02 Humalog® Mix50 Biphasic Insulin Lispro 3ml cartridge (via Humapen® Luxura device)
    3ml disposable prefilled pen (Kwikpen®)
    09.02.02.02 Human Albumin Solution  note This is a BLOOD product. Obtain from haematology (not pharmacy).
    06.05.01 Human Menopausal Gonadotrophins Menopur® Injection
    14.04 Human papilloma virus vaccine Gardasil®
    06.01.01.02 Humulin® I Isophane Insulin 3ml cartridge (via Humapen® Luxura device)
    3ml prefilled disposable pen (Kwikpen®)
    06.01.01.02 Humulin® M3 Biphasic Isophane Insulin 3ml cartridge (via Humapen® Luxura device)
    3ml prefilled disposable pen (Kwikpen®)
    06.01.01.01 Humulin® S  3ml cartridge
    10ml vial
    10.01 Hyaluronic acid  Restricted Item See link
    10.03.01 Hyaluronidase  Injection
    02.05.01 Hydralazine  Tablets
    Injection

    Oral hydralazine may be used in combination with long-acting nitrates in patients with heart failure who are still symptomatic despite optimal therapy with ACE inhibitor and beta blocker or when ACE inhibitors and ARBs are contra-indicated or not tolerated.

    Not to be used as monotherapy (causes tachycardia and fluid retention). (BNF)

    01.05.02 Hydrocortisone  Rectal foam
    Injection
    06.03.02 Hydrocortisone  Tablets
    Injection (as sodium phosphate)
    Injection (as sodium succinate)

    12.03.01 Hydrocortisone Corlan® Oromucosal tablets
    13.04 Hydrocortisone  Cream (0.5%, 1%, 2.5%)
    Ointment (0.5%, 1%, 2.5%)

    13.04 Hydrocortisone 0.5% with Nystatin and Chlorhexidine  Nystaform-HC® Cream
    Ointment
    13.04 Hydrocortisone 0.5% with Nystatin, Benzalkonium and Dimeticone Timodine® Cream
    13.04 Hydrocortisone 1% with Clotrimazole 1% Canesten HC® Cream
    13.04 Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort® Cream
    Ointment
    13.04 Hydrocortisone 1%, Urea 10% and Lactic Acid 5% Calmurid HC® Cream
    10.01.02.02 Hydrocortisone acetate Hydrocortistab® 25mg/ml intra-articular injection
    13.04 Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H® Cream
    12.01.01 Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone® HC Ear drops

    13.04 Hydrocortisone Butyrate 0.1% Locoid® Cream
    Ointment
    12.01.01 Hydrocortisone with Antibactrial Otosporin® Ear drops
    12.03.04 Hydrogen Peroxide  Mouthwash
    13.11.06 Hydrogen Peroxide Solution BP 
    13.02.01.01 Hydromol® bath and shower emollient 
    13.02.01 Hydromol® ointment  Ointment
    09.01.02 Hydroxocobalamin  Injection
    08.01.05 Hydroxycarbamide Hydrea®


    Amber Traffic Light  for essential thrombocythaemia, myelofibrosis or polycythaemia with high risk of complications



    Red Traffic Light  for chemotherapy

    10.01.03 Hydroxychloroquine  Tablets
    03.04.01 Hydroxyzine  Tablets
    Oral Solution

    Hydroxyzine is favoured by dermatologists for its anti-itch and sedating effects.

    10.01 Hylan G-F 20 Synvisc® Restricted Item See link
    01.02 Hyoscine Butylbromide Buscopan® Tablets
    Injection
    04.06 Hyoscine Hydrobromide  Tablets
    Patches
    04.06 Hyoscine Hydrobromide  Tablets
    Patch
    15.01.03 Hyoscine Hydrobromide 
    03.07 Hypertonic sodium chloride  Nebuliser solution
    11.08.01 Hypromellose  0.3% eye drops
    0.5% eye drops
    06.01.01.02 Hypurin® Bovine Isophane Isophane Insulin 3ml cartridges (via Autopen® Classic)

    • Some long-standing type 1 diabetic patients may be on animal insulin.
    • Patients need not be transferred to human insulin unless clinical need dictates
    • Human insulin and analogues should be used in preference to animal insulin
    06.01.01.01 Hypurin® Bovine Neutral  3ml cartridge (for Autopen® Classic)

    • Some long-standing type 1 diabetic patients may be on animal insulin.
    • Patients need not be transferred to human insulin unless clinical need dictates
    • Human insulin and analogues should be used in preference to animal insulin
    06.01.01.02 Hypurin® Porcine 30/70 Mix Biphasic Isophane Insulin 3ml cartridge (for Autopen® Classic)

    • Some long-standing type 1 diabetic patients may be on animal insulin.
    • Patients need not be transferred to human insulin unless clinical need dictates
    • Human insulin and analogues should be used in preference to animal insulin
    06.01.01.02 Hypurin® Porcine Isophane Isophane Insulin 3ml cartridge (via Autopen® Classic)

    • Some long-standing type 1 diabetic patients may be on animal insulin.
    • Patients need not be transferred to human insulin unless clinical need dictates
    • Human insulin and analogues should be used in preference to animal insulin
    06.01.01.01 Hypurin® Porcine Neutral  3ml cartridge (for Autopen® Classic)

    • Some long-standing type 1 diabetic patients may be on animal insulin.
    • Patients need not be transferred to human insulin unless clinical need dictates
    • Human insulin and analogues should be used in preference to animal insulin
    06.01.01.02 Hypurin®Bovine Lente Insulin Zinc suspension 10ml vial

    • Some long-standing type 1 diabetic patients may be on animal insulin.
    • Patients need not be transferred to human insulin unless clinical need dictates
    • Human insulin and analogues should be used in preference to animal insulin
    06.06.02 Ibandronic Acid Bondronat® 50mg Tablets
    Concentrate for infusion

    note Approved for reduction of bone damage in bone metastases in advanced breast cancer

    07.01.01.01 Ibuprofen Pedea® Intravenous solution
    10.01.01 Ibuprofen  Tablets
    Oral suspension
    5% gel
    10.03.02 Ibuprofen gel  Gel
    24.03 Idarubicin IV Infusion 
    24.03 Ifosfamide and Mesna IV Infusion 
    02.05.01 Iloprost   Injection

    unlicensedunlicensed

    For use in rheumatology patients, see attached guidelines.
    04.03.01 Imipramine  Tablets
    Oral solution
    04.07.03 Imipramine  Tablets
    Oral solution
    07.04.02 Imipramine  Tablets
    Oral solution
    13.07 Imiquimod Aldara® 5% Cream
    14.04 Inactivated Influenza Vaccine (Split Virion) 
    03.01.01.01 Indacaterol  Dry powder inhaler 150 microgram/dose, 300 microgram/dose (Onbrez Breezhaler®)

    May be considered as a treatment option for COPD patients in whom another long acting β-adrenoceptor agonist (LABA) would be suitable (GMMMG).

    Not licensed for asthma.
    02.02.01 Indapamide  Tablets

    First choice for hypertension, where a thiazide is indicated (see NICE CG127: Hypertension).

    N.B. Modified release tablets are NON-formulary
    07.01.01.01 Indometacin  Injection
    07.01.03 Indometacin  Suppositories
    Capsules
    unlicensedUnlicensed indication
    10.01.01 Indometacin  Capsules
    Modified-release capsules
    Suppositories
    13.11.01 Industrial Methylated Spirit BP 
    09.04 Infatrini Peptisorb  Dose dependent on age
    01.05.03 Infliximab Remsima® For new patients only
    01.05.03 Infliximab Remicade®
    10.01.03 Infliximab  Intravenous Infusion
    13.05.03 Infliximab Remicade®
    24.03 Infliximab IV Infusion Remsima Outsourced product - not prepared by PAT Aseptic Services
    24.03 Infliximab IV Infusion Remicade
    13.08.01 Ingenol mebutate Picato® Gel

    Restricted Item Dermatology Only
    06.01.01.02 Insulatard® Isophane Insulin 3ml cartridge (via Novopen®4)
    3ml prefilled disposable pen (Innolet®)
    06.01.01.02 Insuman® Basal Isophane Insulin 3ml cartridge (via ClikSTAR® or Autopen®24 devices)
    3ml prefilled disposable pen (Solostar®)
    06.01.01.02 Insuman® Comb 15 Biphasic Isophane Insulin 3ml cartridge (via ClikSTAR® or Autopen®24 devices)
    06.01.01.02 Insuman® Comb 25 Biphasic Isophane Insulin 3ml cartridge (via ClikSTAR® or Autopen®24 devices)
    3ml prefilled disposable pen (Solostar®)
    06.01.01.02 Insuman® Comb 50 Biphasic Isophane Insulin 3ml cartridge (via ClikSTAR® or Autopen®24 devices)
    06.01.01.01 Insuman® Rapid  3ml cartridge (via ClikSTAR® or Autopen® 24)

    08.02.04 Interferon Alfa-2b IntronA®
    08.02.04 Interferon Alfa-2b Roferon-A®
    24.02 Intralipid 20% with 10mls Vitlipid N Infant 
    07.03.04 Intra-uterine Contraceptive Devices TT 380 Slimline®
    07.03.02.03 Intra-uterine Progestogen Only System Mirena®
    03.01.02 Ipratropium  Metered dose inhaler (MDI) 20 micrograms/dose
    Nebuliser solution 250 micrograms/ml, 500 micrograms/ml

    12.02.02 Ipratropium Bromide Rinatec®
    02.05.05.02 Irbesartan  Tablets

    GMMMG endorse use for renal patients.
    09.01.01.02 Iron Dextran CosmoFer® Injection

    09.01.01.02 Iron Isomaltoside Monofer® Injection

     
    09.01.01.02 Iron Sucrose Venofer® Injection
    15.01.02 Isoflurane 
    05.01.09 Isoniazid  Tablets
    Injection
    02.07.01 Isoprenaline  Concentrate for injection or infusion (dilute before use).
    unlicensedunlicensed

    02.06.01 Isosorbide Dinitrate  Injection

    02.06.01 Isosorbide Mononitrate  Modified release tablets
    Tablets

    13.06.02 Isotretinoin Roaccutane® Capsules

    Restricted Item Dermatology only
    01.06.01 Ispaghula Husk  Granules
    05.02.01 Itraconazole  Capsules
    Oral Liquid
    Intravenous Infusion

    Itraconazole is associated with liver damage and should no be given to patients with a history of liver disease.

    Following reports of heart failure, caution is advised when prescribing itraconazole to patients at high risk of heart failure (BNF).
    02.06.03 Ivabradine  Tablets


    Restricted Item Specialist initiation

    Ivabradine should only be initiated in people with NYHA class II to IV stable chronic heart failure with systolic dysfunction who:
  • are in sinus rhythm with a heart rate of 75 bpm or more
  • have a left ventricular ejection fraction of 35% or less, AND
  • who have been stable for 4 weeks on optimised standard therapy with ACE inhibitors, beta-blockers and aldosterone antagonists (or when beta-blockers are contra-indicated or not tolerated).
  • 05.05.06 Ivermectin  Tablets

    unlicensedunlicensed
    05.05.07 Ivermectin  Tablets

    unlicensedunlicensed
    05.05.08 Ivermectin  Tablets

    unlicensedunlicensed
    13.10.04 Ivermectin  Tablets

    unlicensedunlicensed

    14.04 Japanese Encephalitis Vaccine Ixiaro® Restricted Item NMGH Travel Clinic only
    09.04.02 Jevity  500ml
    1000ml
    1500ml
    09.04.02 Jevity 1.5kcal  500ml
    1000ml
    1500ml
    09.04.02 Jevity PLUS  500ml
    1000ml
    1500ml
    09.04.02 Jevity PLUS HP 
    09.04.02 Jevity Promote 
    04.07.03 Ketamine oral solution  Specialist initiation by pain team or palliative care only
    unlicensed Unlicensed
    07.02.02 Ketoconazole 2%  Cream
    13.10.02 Ketoconazole 2% Cream Nizoral® Cream
    13.09 Ketoconazole 2% Shampoo  Shampoo
    10.03.02 Ketoprofen gel  Gel
    11.08.02 Ketorolac Acular® Eye drops

    Restricted Item Ophthalmic specialist initiation only
    15.01.04.02 Ketorolac Toradol®
    09.06.07 Ketovite®  Tablets
    Liquid
    01.06.05 Klean-Prep® 
    06.04.01.01 Kliofem®   Tablets

    Estradiol 2mg + norethisterone acetate 1mg
    06.04.01.01 Kliovance®   Tablets

    Estradiol 1mg + norethisterone acetate 500micrograms
    02.04 Labetalol  Tablets
    Injection
    Infusion

    Labetalol is a first line option for the management of hypertension in pregnancy (see NICE Guidance - Hypertension in Pregnancy).
    04.08.01 Lacosamide   Tablets
    Syrup
    01.06.04 Lactulose Solution  note  Lactulose takes up to 48 hours to work but is often inappropriately used “when required”. It is unpleasant to take and compliance may be a problem. Its main clinical benefit is in the management of hepatic encephalopathy.
    05.03.01 Lamivudine  Tablets
    Oral Solution
    05.03.03.01 Lamivudine  Tablets
    Oral Solution
    04.08.01 Lamotrigine  Tablets
    Dispersible tablets
    08.03.04.03 Lanreotide Somatuline® Injection (Somatuline® LA and Somatuline® Autogel)


    Amber Traffic Light  for acromegaly



    Red Traffic Light  other indications

    01.03.05 Lansoprazole  Capsules
    Orodispersible tablets - first choice for patients with enteral feeding tubes
    09.05.02.02 Lanthanum Fosrenol ® Tablets

    06.01.01.02 Lantus® Insulin Glargine 3ml cartridge (via ClikSTAR® or Autopen®24 devices)
    3ml prefilled disposable pen (Solostar®)

    11.06 Latanoprost  Eye drops
    Single-use eye drops
    11.06 Latanoprost 0.005% with Timolol 0.5%  Eye drops

    Combination products are licensed for once daily use where prostaglandin analogue alone is not adequate. Only use where patient has difficulty with compliance/administration.
    05.03.03.02 Ledipasvir/Sofosbuvir Harvoni® 90mg/400mg Tablets

    Restricted Item  Requires MDT discussion with ID team
    10.01.03 Leflunomide  Tablets

    Restricted Item Specialist Initiation Only
    08.02.04 Lenalidomide Revlimid® Capsules
    09.01.06 Lenograstim Granocyte® Injection
    02.06.02 Lercanidipine  Tablets
    08.03.04.01 Letrozole  Tablets

    06.07.02 Leuprorelin Prostap® Prefilled dual chamber syringe
    3.75mg (monthly)
    11.25mg (every 3 months)

    note For use in prostate cancer, see section 8.3.4.2.

    "Amber" for licensed indications, "Red" for all unlicensed uses.
    08.03.04.02 Leuprorelin Acetate Prostap® Prostap®3 DCS 11.25mg injection
    Prostap® SR DCS 3.75mg injection

    1st choice for prostate cancer


    Amber Traffic Light  For licensed indications


    05.05.02 LEVAMISOLE Tablets 50 mg  Tablets

    unlicensedunlicensed
    06.01.01.02 Levemir® Insulin Detemir 3ml cartridges (via Novopen®4 device)
    3ml prefilled disposable pen (Flexpen® or Innolet®)
    04.08.01 Levetiracetam Keppra® Tablets
    Oral solution
    Intravenous infusion
    11.06 Levobunolol  Eye drops
    Unit dose eye drops
    15.02 Levobupivacaine Chirocaine®
    05.01.12 Levofloxacin  Tablets
    Intravenous Infusion
    11.03.01 Levofloxacin  Eye drops
    Unit dose eye drops
    13.03 Levomenthol Dermacool® Cream
    04.02.01 Levomepromazine  Tablets
    Injection
    04.06 Levomepromazine  Tablets
    Injection

    noteIn the last days of life, levomepromazine is used as a first-line antiemetic.
    04.06 Levomepromazine  Tablets
    Injection
    07.03.05 Levonorgestrel Levonelle® 1500
    06.02.01 Levothyroxine  Tablets
    Oral liquid
    12.03.01 Lidocaine   10% mouth spray
    5% ointment
    15.02 Lidocaine 
    01.07.01 Lidocaine 5%   Ointment
    11.07 Lidocaine Hydrochloride 4% with Fluorescein 0.25% Minims® Single-use eye drops
    01.06.07 Linaclotide Constella® Capsules
    Restricted Item Gastroenterologists only
    06.01.02.03 Linagliptin Trajenta® Tablets

    note First choice 'Gliptin' for patients with moderate or severe renal impairment (CrCl<50ml/min, eGFR<59ml/min)
    05.01.07 Linezolid  Tablets
    Suspension
    Intravenous Infusion

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    06.02.01 Liothyronine 

    Tablets
    DotFor patients who, in exceptional circumstances, have an on-going need for liothyronine as confirmed by a consultant endocrinologist

    DotFor patients with thyroid cancer prior to radioiodine treatment

    Injection

    DotFor acutely unwell patients with profound hypothyroidism

    13.02.01 Lipobase®  Cream

    Restricted Item Dermatology only
    13.02.01 Liquid and White Soft Paraffin Ointment (50:50)  Ointment
    11.08.01 Liquid Paraffin Lacri-Lube® Eye ointment
    06.01.02.03 Liraglutide Victoza® Disposable pen
    04.04 Lisdexamfetamine Elvanse® Capsules

    Restricted Item Pennine Care: Use may be considered second or third line when treatment with methylphenidate m/r not successful and patient has swallowing difficulties (as atomoxetine caps cannot be opened) and where drug diversion is not a risk.
    02.05.05.01 Lisinopril  Tablets
    04.02.03 Lithium Carbonate tablets Camcolit® or Priadel®
    04.02.03 Lithium Citrate liquid Li-Liquid® or Priadel®
    06.01.02.03 Lixisenatide Lyxumia® Disposable pen
    11.04.02 Lodoxamide Alomide® Eye drops
    07.03.01 Loestrin 20®  Ethinylestradiol 20 mcg / norethisterone 1mg Low strength preparation
    04.03.01 Lofepramine  Tablets
    Oral suspension
    04.10.03 Lofexidine Hydrochloride  Specialist initiation only
    07.03.01 Logynon®  Ethinylestradiol / levonorgestrel phased pill Tri-phasic preparation
    01.04.02 Loperamide  Capsules
    Syrup
    05.03.01 Lopinavir and Ritonavir Kaletra®
    03.04.01 Loratadine  Tablets
    Oral Solution
    04.01.02 Lorazepam  Tablets
    Injection
    15.01.04.01 Lorazepam 
    04.08.02 Lorazepam Injection 
    02.05.05.02 Losartan  Tablets


    05.01.03 Lymecycline  Capsules
    13.06.02 Lymecycline  Capsules

    Restricted Item To be initiated by Dermatology only

    Alternative choice for acne only
    01.06.04 Macrogol Movicol® sachet
    09.05.01.03 Magnesium Aspartate Magnaspartate® Sachets

    09.05.01.03 Magnesium Sulphate  50% Injection
    10% Injection

    1 gram Mg = 4 mmol Mg.

    13.10.05 Magnesium Sulphate Paste BP  Paste
    01.01.01 Magnesium Trisilicate Mixture BP 
    13.10.04 Malathion 0.5% Derbac-M® Liquid
    13.10.04 Malathion 0.5% Derbac-M® Liquid
    02.02.05 Mannitol  Intravenous Infusion
    05.03.01 Maraviroc 
    14.04 Measles, Mumps and Rubella Vaccine, Live (MMR) 
    05.05.01 Mebendazole  Chewable tablets
    Oral suspension
    05.05.04 Mebendazole  See section 5.5.1
    01.02 Mebeverine Hydrochloride  Tablets
    Oral suspension
    06.04.01.02 Medroxyprogesterone Acetate  Tablets
    07.03.02.02 Medroxyprogesterone Acetate Depo-Provera® 12-weekly IM injection
    08.03.02 Medroxyprogesterone Acetate Provera® Tablets
    10.01.01 Mefenamic Acid  Capsules
    Tablets
    Oral suspension
    05.04.01 Mefloquine  Tablets
    08.03.02 Megestrol Acetate Megace® Tablets
    04.01.01 Melatonin  M/R tablets
    unlicensedCapsules (unlicensed)
    unlicensed Tablets (unlicensed)
    unlicensed Oral liquid (unlicensed)


    Green Traffic Light  applies when licensed product used in adult patients over 55

    note The licensed M/R tablets can be crushed for administration in dysphagia or via enteral feeding tubes if necessary. This obviously means that they would no longer be 'modified release'.
    10.01.01 Meloxicam  Tablets
    04.11 Memantine  Tablets
    Oral solution

    Green Traffic Light Commissioning arrangements may vary and in some localities this is Green2 - check with relevant CCG
    09.06.06 Menadiol Sodium Phosphate  Tablets

    Water-soluble. For use in patients with fat malabsorption syndromes, e.g. biliary obstruction or hepatic disease (BNF)
    14.04 Meningococcal group B Vaccine Bexsero®
    14.04 Meningococcal group C conjugate vaccine NeisVac-C®
    14.04 Meningococcal polysaccharide A, C, W135 and Y vaccine Nimenrix® or Menveo®
    01.05.03 Mercaptopurine  Tablets
    05.01.02.02 Meropenem  Injection

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    01.05.01 Mesalazine  Mezavant® XL Tablets

    Restricted Item Specialist initiation only

    note For when symptoms are not controlled with 400mg or 800mg preparations or when concordance is an issue.
    01.05.01 Mesalazine Asacol® Tablets
    Foam enema
    Suppositories
    01.05.01 Mesalazine Pentasa® Tablets
    Granules
    Retention enema
    Suppositories


    noteTablets may be dispersed in water for patients with dysphagia / enteral feeding tubes

    01.05.01 Mesalazine Salofalk® Granules

    note Granules may be used for patients with swallowing difficulties. Tablets are NON FORMULARY
    01.05.01 Mesalazine Octasa® Tablets
    08.01 Mesna  Tablets
    Injection
    24.01 Mesna IV Infusion 
    13.02.02 Metanium®  Ointment
    02.07.02 Metaraminol  Injection

    unlicensedunlicensed
    06.01.02.02 Metformin  Tablets
    Oral Solution


    Green Traffic Light Green3 when used in pregnancy or PCOS

    06.01.02.02 Metformin Hydrochloride Modified Release MR Tablets

    Metformin MR should only be used where the standard metformin tablets have been tried and are not tolerated due to GI problems. Any new prescription of the MR preparation should be reviewed soon after initiation (recommend checking HbA1c after 3 months and assess patient for adherence to treatment/adverse effects), discontinue if not tolerated or ineffective.
    04.10.03 Methadone  Solution
    Injection
    03.09.01 Methadone Hydrochloride Methadone® Linctus Oral solution

    Methadone has been used to control distressing cough in terminal lung cancer, although morphine is now preferred. In other circumstances, it is contraindicated because it induces sputum retention and ventilatory failure. Also causes opioid dependence, has a long duration of action, and tends to accumulate. (BNF 67)

    10.01.03 Methotrexate  Tablets
    Pre-filled injection pen (supplied to patients via homecare arrangements)

    Restricted Item Specialist initiation only

    WEEKLY dosing
    13.05.03 Methotrexate  Tablets
    Injection
    01.05.03 Methotrexate - injection 
    01.05.03 Methotrexate - oral  Tablets
    24.03 Methotrexate IM Injection 
    24.03 Methotrexate Intrathecal Injection 
    24.03 Methotrexate IV Infusion 
    13.05.02 Methoxypsoralen  Tablets

    Restricted Item Dermatology only
    01.06.01 Methycellulose Celevac® Tablets
    13.08.01 Methyl-5-Aminolevulinate Metvix® Cream

    Restricted Item Dermatology Only
    02.05.02 Methyldopa  Tablets

    Used in the management of hypertension in pregnancy
    04.04 Methylphenidate  Tablets
    M/R tablets or capsules

    First choice brand for Pennine Care is Matoride XL.
    06.03.02 Methylprednisolone  Injection
    Depot injection
    Tablets
    10.01.02.02 Methylprednisolone Acetate Depo-Medrone® Injection
    10.01.02.02 Methylprednisolone Acetate Depo-Medrone® with Lidocaine Injection
    01.02 Metoclopramide  Tablets
    Oral solution
    Injection

    note Should only be prescribed for short-term use (up to 5 days). For adults, the maximum dose in 24 hours is 30mg.
    04.06 Metoclopramide  Tablets
    Oral solution
    Injection
    04.06 Metoclopramide  Tablets
    Oral solution
    Injection
    04.06 Metoclopramide  Tablets
    Suspension
    Injection
    02.02.01 Metolazone  Tablets

    unlicensedunlicensed
    UK licensed product discontinued in 2012. Unlicensed import product is available from Pharmacy.

    02.04 Metoprolol   Tablets (not a preferred GMMMG option)
    Injection

    05.01.11 Metronidazole  Tablets
    Oral suspension
    Suppositories
    Intravenous Infusion
    05.04.02 Metronidazole  See section 5.1.11
    07.02.02 Metronidazole  Vaginal gel
    13.10.01.02 Metronidazole gel  Gel
    06.07.03 Metyrapone Metopirone® Capsules

    Restricted Item For specialist use only
    04.03.01 Mianserin 
    07.02.02 Miconazole  Cream
    12.03.02 Miconazole Daktarin® Oral Gel
    13.10.02 Miconazole 2% Cream  Cream
    07.03.01 Microgynon 30 ED®  Ethinylestradiol 30 mcg / levonorgestrel 150 mcg Standard strength, everyday preparation
    07.03.01 Microgynon 30® or Levest® Ethinylestradiol 30mcg / levonorgestrel 150mcg Standard strength preparation
    07.03.02 Micronor®  Norethisterone 350mcg
    15.01.04.01 Midazolam Hypnovel®
    04.08.02 Midazolam Buccal Solution Buccolam® Restricted Item Paediatric use only
    02.07 Midodrine  Tablets
    Restricted Item For hypotensive states. Not to be initiated in primary care.


    07.01.02 Mifepristone Mifegyne® Tablets
    04.07.04.01 Migraleve®  "Pink" tablets (buclizine 6.25mg, paracetamol 500mg, codeine phosphate 8mg)
    "Yellow" tablets (paracetamol 500mg, codeine phosphate 8mg)
    07.04.02 Mirabegron  M/R tablets

    Only recommended if antimuscarinic drugs are contraindicated, clinically ineffective or have unacceptable side effects.
    04.03.04 Mirtazapine  Tablets
    Orodispersible tablets
    07.01.01 Misoprostol  Tablets (for oral or vaginal administration)
    unlicensedUnlicensed indication
    07.04.04 Mitomycin  Bladder instillation
    11.99.99.99 Mitomycin C   Subconjunctival injection

    Prepared by pharmacy aseptics unit on named-patient basis
    24.03 Mitoxantrone IV Infusion 
    15.01.05 Mivacurium Chloride Mivacron®
    04.03.02 Moclobemide 
    04.04 Modafinil  Tablets

    AMBER for sleepiness associated with narcolepsy

    12.02.01 Mometasone Furoate Nasonex® Nasal Spray
    13.04 Mometasone Furoate 0.1% Non-proprietary or Elocon® Cream
    Ointment

    Restricted Item Dermatology only
    03.03.02 Montelukast Singulair® Tablets
    Restricted Item Chewable Tablets
    Restricted Item Granules

    Restricted Item The Scottish Medicines Compendium has advised (June 2007) that montelukast chewable tablet and granules are restricted for use as an alternative treatment option to low-dose inhaled corticosteroids for children 2 to 14 years of age with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids.

    The chewable tablets and granules should be initiated by specialists in paediatric asthma care.

    04.07.02 Morphine  Oral solution:
  • 10mg/5mL
  • 100micrograms/mL (unlicensedunlicensed)

    Concentrated oral solution:
  • 100mg/5mL

    Tablets

    M/R 12-hourly oral preparations:
  • Zomorph® capsules
  • MST® tablets

    M/R 24-hourly oral preparations:
  • MXL® capsules

    Suppositories

    Injection

    PCA syringe (unlicensedunlicensed)

  • 01.06.05 Moviprep® 
    05.01.12 Moxifloxacin  Tablets
    Intravenous Infusion

    Restricted Item Can only be prescribed following discussion with Microbiology or an ID physician
    02.05.02 Moxonidine  Tablets

    Restricted Item Specialist initiation only

    Moxonidine is considered a last-line management option for resistant hypertension.

    09.06.07 Multivitamin preparations Abidec® Oral drops
    09.06.07 Multivitamin preparations Dalivit® Oral drops

    Only use if Abidec is unavailable
    13.10.01.01 Mupirocin Bactroban® See 12.02.03
    12.02.03 Mupirocin 2% in White Soft Paraffin Bactroban Nasal® Nasal ointment

    Restricted Item For MRSA eradication only
    09.06.07 Mutivitamins   Capsules
    10.01.03 Mycophenolate  Tablets
    Capsules


    unlicensedunlicensed indication (rheumatoid arthritis).
    08.02.01 Mycophenolate Mofetil  Capsules
    Tablets
    Oral suspension

    note All new patients commenced on mycophenolate mofetil should be commenced on a "branded generic" preparation.
    13.05.03 Mycophenolate mofetil  Tablets
    Capsules
    Oral suspension

    unlicensedunlicensed indication (severe refractory eczema)
    08.02.01 Mycophenolic Acid Myfortic® Gastro-resistant tablets

    note Mycophenolate and mycophenolic acid are not interchangeable. Patients on Myfortic® must remain on Myfortic®.
    08.02.01 Mycophenolic Acid Myfortic® Gastro-resistant tablets

    note Mycophenolate and mycophenolic acid are not interchangeable. Patients on Myfortic® must remain on Myfortic®.
    24.03 Mytomycin Ophthalmic 
    10.01.01 Nabumetone  Tablets
    Oral suspension
    02.06.04 Naftidrofuryl Oxalate  Tablets

    Naftidrofuryl is an option for the treatment of intermittent claudication in people with peripheral arterial disease for whom vasodilator therapy is considered appropriate after taking into account other treatment options. See NICE TA223: Peripheral Arterial Disease.
    04.10.01 Naltrexone  Tablets
    04.10.03 Naltrexone  Specialist initiation only
    10.01.01 Naproxen  Tablets
    06.01.02.03 Nateglinide Starlix® Tablets
    02.04 Nebivolol Nebilet® Tablets

    Highly cardio-selective. Can be considered in patients with severe COPD or asthma, when benefits of beta-blockade are thought to outweigh the respiratory risks, under specialist supervision with PEFR monitoring in hospital. Can also be tried in patients who develop wheeze with less cardioselective beta-blockers.

    Usual to start at 1.25mg and uptitrate. This will involve the use of quarter of a 5mg tablet.
    11.04.02 Nedocromil Rapitil® Eye drops
    04.07.01 Nefopam  Tablets

    Only to be used in those patients with moderate to severe chronic liver disease who require analgesia stronger than paracetamol in whom NSAIDS and moderate strength opiates are contraindicated
    09.04 Neocate Active 
    09.04.02 Neocate Advance  Dose calculated by dietitian
    09.04 Neocate LCP  Dose dependent on age
    09.04 Neocate Spoon  Dose dependent on age
    05.01.04 Neomycin Sulphate  Tablets
    12.01.01 Neomycin Sulphate with corticosteroids Otosporin® Ear drops

    Not on GMMMG formulary
    24.02 Neonatal PN Concentrated 
    24.02 Neonatal PN Maintenance 
    10.02.01 Neostigmine  Tablets
    Injection (see chapter 15)
    15.01.06 Neostigmine with Glycopyrronium 
    05.03.01 Nevirapine Viramune®
    05.05.03 Niclosamide  Tablets

    unlicensedunlicensed
    02.06.03 Nicorandil Ikorel® Tablets

    Indicated for stable angina only in patients whose angina is inadequately controlled by first-line anti-anginal therapies, or who have a contra-indication or intolerance to first-line therapies, such as beta-blockers and/or calcium channel blockers.
    04.10.02 Nicotine Nicorette® Patch (16 hour)
    Chewing gum
    S/L tablets
    Inhalator

    04.10.02 Nicotine Nicotinell® Patch (24 hour)
    Lozenge
    02.06.02 Nifedipine  Modified release capsules
    Standard release capsules Restricted Item Raynauds phenomenon. Not recommended for angina prophylaxis or hypertension

    Specify the brand when prescribing a modified release nifedipine preparation.

    Short-acting formulations of nifedipine are not recommended for angina or long-term management of hypertension; their use may be associated with large variations in blood pressure and reflex tachycardia. (BNF)
    07.01.03 Nifedipine  Capsules
    unlicensedUnlicensed indication
    02.06.02 Nimodipine Nimotop® Tablets
    Intravenous Infusion

    Restricted ItemFor prevention (oral) and treatment (IV) of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage.
    04.01.01 Nitrazepam  Tablets
    Oral suspension
    05.01.13 Nitrofurantoin  Tablets
    Capsules
    M/R capsules
    Oral Suspension

    15.01.02 Nitrous oxide 
    02.07.02 Noradrenaline / Norepinephrine  Injection (for intravenous infusion; dilute before use).
    06.04.01.02 Norethisterone  Tablets
    07.03.02 Norgeston®  Levonorgestrel 30mcg
    07.03.02 Noriday®  Norethisterone 350mcg
    07.03.01 Norimin®  Ethinylestradiol 35 mcg / noresthisterone 1mg Standard strength preparation
    14.05.01 Normal immunoglobulin for Intravenous use Vigam® Restricted Item Established patients only
    14.05.01 Normal immunoglobulin for Intravenous use Octagam®
    14.05.01 Normal immunoglobulin for subcutaneous or intramuscular use Subgam®

    Restricted Item Only for prophylaxis of tetanus-prone wounds when IM tetanus immunoglobulin unavailable

    See Public Health England (PHE) Guidance for full details

    04.03.01 Nortriptyline  Tablets
    06.01.05 Nortriptyline  Tablets

    unlicensedunlicensed

    note Useful if the patient gains benefit from amitriptyline but experiences side/adverse effects
    06.01.01.02 NovoMix® 30 Biphasic Insulin Aspart 3ml cartridge (via Novopen® 4 device)
    3ml prefilled disposable pen (Flexpen®)

    06.01.01.01 NovoRapid® Insulin Aspart 3ml cartridge (via Novopen® devices)
    3ml prefilled disposable pen (Flexpen®)
    09.04 Nutriprem 2  Dose dependent on age
    09.04 Nutriprem Hydrolysed  Dose dependent on age
    07.03.01 NuvaRing® Ethinylestradiol / etonogestrel Low strength vaginal ring
    12.03.02 Nystatin Nystan® Oral suspension
    13.10.02 Nystatin Cream  Cream
    13.10.02 Nystatin with Chlorhexidine cream Nystaform® Cream
    08.02.03 Obinutuzumab Gazyvaro® Concentrate for intravenous infusion
    Restricted Item Specialist use only; for previously untreated chronic lymphocytic leukaemia (CLL) in patients with comorbidities making them unsuitable for full-dose fludarabine-based therapy
    24.03 Obinutuzumab IV Infusion 
    08.03.04.03 Octreotide  Solution for injection (various forms)
    Depot injection (Sandostatin LAR®)


    Amber Traffic Light  for acromegaly



    Red Traffic Light  other indications

    07.02.01 Oestrogens, Topical Vagifem® Vaginal tablets
    07.02.01 Oestrogens, Topical Gynest® 0.01% intravaginal cream
    08.02.03 Ofatumumab Arzerra® Concentrate for intravenous infusion

    Restricted Item Specialist use only; CDF criteria must be met & funding approval received.
    24.03 Ofatumumab IV Infusion 
    05.01.12 Ofloxacin  Tablets

    (Intravenous infusion is non-formulary)
    11.03.01 Ofloxacin Eye drops  Eye drops

    13.02.01 Oilatum®  Cream
    13.02.01.01 Oilatum® Bath Additive 
    13.02.01.01 Oilatum® Plus  emollient bath additive
    13.02.01.01 Oilatum®Plus Bath Additive 
    01.07.03 Oily Phenol Injection BP  Specialist administration only
    04.02.01 Olanzapine  Tablets
    Orodispersible tablets
    12.01.03 Olive Oil Ear Drops  Ear drops

    11.04.02 Olopatadine Opatanol® Eye drops
    01.05.01 Olsalazine  Capsules
    Tablets

    Restricted Item Specialist initiation only
    03.04.02 Omalizumab Xolair® Subcutaneous injection
    05.03.03.02 Ombitasvir/Paritaprevir/Ritonavir Viekirax® 12.5mg/75mg/50mg Tablets

    Restricted Item  Requires MDT discussion with ID team
    02.12 Omega-3-Acid Ethyl Esters  Capsules

    Restricted Item Should only be used for the treatment of hypertriglyceridaemia under the care of a lipid management specialist.

    Omega-3-Acid Ethyl Esters are NOT recommended for the secondary prevention of Myocardial Infarction. See GMMMG IPNTS recommendation.
    01.03.05 Omeprazole  Capsules
    Injection Restricted Item Only for use in ventilated patients to prevent ventilator associated pneumonia and in patients who have received an endoscopic intervention for upper gastro-intestinal bleeding.

    Swallowing difficulties: Patients can open the capsule and swallow the contents with half a glass of water or mix the contents in fruit juice or non-carbonated water. Patients should be advised that the dispersion should be taken within 30 minute and always be stirred just before drinking and rinsed down with half a glass of water.
    04.06 Ondansetron  Tablets
    Injection
    Oral lyophilisates (’melts’)
    Suppositories


    Green Traffic Light For exceptional use in non-oncology patients with chronic emesis following consultant recommendation and where all other options have failed
    04.06 Ondansetron  Tablets
    Oral lyophilisates ('melts')
    Injection
    Suppositories
    04.09.01 Opicapone Ongentys® Capsules
    06.01.06 Oral glucose tolerance test. 
    09.02.01.02 Oral Rehydration Salts e.g. Dioralyte® Oral powder
    04.05.01 Orlistat 
    04.09.02 Orphenadrine  Tablets
    Oral liquid
    05.03.04 Oseltamivir Tamiflu® Capsules
    Oral Suspension
    09.04.02 Osmolite  500ml
    1000ml
    1500ml
    09.04.02 Osmolite 1.5kcal  500ml
    1000ml
    1500ml
    09.04.02 Osmolite HP 
    09.04.02 Osmolite PLUS  500ml
    1000ml
    1500ml
    07.03.01 Ovysmen®  Ethinylestradiol 35 mcg / noresthisterone 500mcg Standard strength preparation
    04.01.02 Oxazepam 
    04.08.01 Oxcarbazepine  Tablets
    11.07 Oxybuprocaine Hydrochloride Minims® Single-use eye drops
    07.04.02 Oxybutynin  Tablets
    M/R tablets
    Patches (Restricted Item only when the oral route is not tolerated)
    04.07.02 Oxycodone  Immediate-release preparations (OxyNorm®):
  • Oral solution 5mg/5mL
  • Concentration oral solution 10mg/mL
  • Capsules
  • Injection

    M/R preparations (OxyContin®):
  • Tablets
  • 05.01.03 Oxytetracycline  Tablets
    13.06.02 Oxytetracycline  Tablets

    First choice for acne and rosacea
    07.01.01 Oxytocin Syntocinon® Injection
    09.04 Paediasure 200ml Bottle 
    09.04.02 Paediasure 500ml Bag  Dose calculated by dietitian
    09.04 Paediasure Fibre 200ml Bottle  Dose dependent on age
    09.04.02 Paediasure Fibre 500ml Bag  Dose calculated by dietitian
    09.04 Paediasure Peptide 200ml Bottle 
    09.04.02 Paediasure Peptide 500ml Bag  Dose calculated by dietitian
    09.04 Paediasure Plus 200ml Bottle  Dose dependent on age
    09.04.02 Paediasure Plus 500ml Bag  Dose calculated by dietitian
    09.04 Paediasure Plus Fibre 200ml Bottle 
    09.04.02 Paediasure Plus Fibre 500ml Bag  Dose calculated by dietitian
    09.04 Paediasure Plus Juice 200ml Bottle 
    05.03.05 Palivizumab Synagis® Injection
    04.06 Palonosetron Aloxi® Approved for emesis following breast cancer chemotherapy (2nd line after ondansetron)
    05.01.09 P-aminosalicylic acid Paser® Sachets

    unlicensedunlicensed

    Restricted Item Can only be prescribed following discussion with an ID physician
    01.09.04 Pancreatin Creon® 10000
    01.09.04 Pancreatin Creon® Micro
    01.09.04 Pancreatin Creon® 25000
    01.09.04 Pancreatin Pancrex V® note For administration via enteral feeding tubes
    01.09.04 Pancreatin Creon® 40000
    15.01.05 Pancuronium Bromide 
    04.07.01 Paracetamol  Tablets
    Soluble tablets
    Oral suspension
    Suppositories
    IV infusion
    04.07.01 Paracetamol and codeine Co-codamol® 8/500 Tablets
    Effervescent tablets
    04.07.01 Paracetamol and codeine Co-codamol® 30/500 Tablets
    Effervescent tablets
    04.07.01 Paracetamol and dihydrocodeine Co-dydramol® 10/500 Tablets
    04.08.02 Paraldehyde Enema  Restricted Item Paediatric use only
    15.01.04.02 Parecoxib Dynastat®
    09.03 Parenteral Nutrition (TPN)  See Chapter 24 for full list of TPN bags available.

    Please see Appendix 3 of attached link for details on out-of-hours TPN use
    04.03.03 Paroxetine  Tablets
    Oral suspension
    09.01.06 Pegfilgrastim Neulasta® Injection
    05.03.03.01 Peginterferon Alfa  Injection
    05.03.03.02 Peginterferon Alfa  Injection
    08.02.04 Peginterferon Alfa Pegasys® First line choice for chronic hepatitis C
    08.02.04 Peginterferon Alfa ViraferonPeg® For chronic hepatitis C patients >120kg in weight.
    09.08.01 Penicillamine  Tablets
    10.01.03 Penicillamine  Tablets
    11.03.01 Penicillin G   Eye drops unlicensedunlicensed special

    05.04.05 Pentamidine Isetionate  Injection
    05.04.08 Pentamidine Isetionate  Injection
    24.01 Pentamidine IV Infusion 
    24.03 Pentostatin IV Infusion 
    02.06.04 Pentoxifylline Trental® Tablets

    Restricted Item For alcoholic liver disease.

    Not recommended for the treatment of intermittent claudication in patients with peripheral arterial disease, but patients currently taking pentoxifylline should have the option to continue until they and their clinican considers it appropriate to stop. (NICE TA223:Peripheral Arterial Disease)
    01.02 Peppermint Oil e/c capsules 
    09.04 Pepti Junior Cow and Gate Dose dependent on age
    04.08.01 Perampanel Fycompa® Tablets
    04.09.01 Pergolide  Tablets
    04.02.01 Pericyazine  Tablets
    02.05.05.01 Perindopril erbumine  Tablets

    Prescribers are reminded that perindopril should be prescribed generically. Perindopril arginine (Coversyl Arginate®) is not dose equivalent and is not included in the formulary.

    13.10.04 Permethrin 1% Lyclear® Creme Rinse INSUFFICIENT CONTACT TIME, THEREFORE NOT RECOMMENDED
    13.10.04 Permethrin 5% Lyclear® Dermal Cream Cream
    04.02.01 Perphenazine  Tablets
    04.07.02 Pethidine  Tablets
    Injection
    04.03.02 Phenelzine 
    02.08.02 Phenindione  Tablets
    02.08.02 Phenindione  Tablets
    04.08.01 Phenobarbital  Tablets
    Elixir
    Injection

    note Ensure patients are maintained on a specific manufacturer's product / brand
    04.08.02 Phenobarbital Injection 
    02.05.04 Phenoxybenzamine Hydrochloride  Capsules
    (Injection is non-formulary)
    05.01.01.01 Phenoxymethylpenicillin  Tablets
    Oral Solution
    02.05.04 Phentolamine Rogitine® Injection

    For hypertensive episodes due to phaeochromocytoma, e.g. during surgery (BNF).
    02.07.02 Phenylephrine  Injection
    11.05 Phenylephrine Hydrochloride Minims® Phenylephrine Hydrochloride 2.5% and 10% Single-use eye drops
    04.08.01 Phenytoin  Capsules
    Suspension 30mg/5mL
    Chewable tablets
    Injection

    note Ensure patients are maintained on a specific manufacturer's product / brand
    04.08.02 Phenytoin Injection  Loading Dose See loading doses policy
    03.09.01 Pholcodine  Oral solution
    09.05.02.01 Phosphate effervescent tablets Phosphate-Sandoz®
    09.05.02.01 Phosphate Polyfusor®  500ml Polyfusor
    01.06.05 Phosphates (oral) Fleet Phospho-soda®
    01.06.04 Phosphates Enema  
    09.06.06 Phytomenadione  1ml amps (Konakion®MM)
    0.2ml amps (Konakion®MM Paediatric) - may be given orally

    11.06 Pilocarpine  1%, 2%, 4% eye drops
    2% single-use eye drops (Minims®)

    13.05.03 Pimecrolimus 1% Cream Elidel® Cream

    Restricted Item Consultant Dermatologist only, in line with NICE Guidance



    04.02.01 Pimozide  Tablets
    06.01.02.03 Pioglitazone Actos® Tablets
    05.01.01.04 Piperacillin and Tazobactam  Injection
    04.02.02 Pipotiazine Palmitate Piportil®
    10.03.02 Piroxicam gel  Gel
    05.01.01.05 Pivmecillinam Hydrochloride Selexid® Tablets
    24.03 Pixantrone IV Infusion 
    04.07.04.02 Pizotifen  Tablets
    14.04 Pneumococcal vaccine Prevenar 13®
    14.04 Pneumococcal vaccine  Previously known as Pneumovax II®
    13.07 Podophyllotoxin Condyline®or Warticon®
    09.04 Polycal  Dose calculated by dietitian
    06.01.06 Polycal® 
    13.10.01.01 Polyfax® Ointment  Ointment
    14.04 Polysaccharide vaccine for injection Typhim Vi®
    09.02.01.01 Polystyrene Sulphonate Resins Calcium Resonium® Powder
    13.09 Polytar AF®  Shampoo
    13.09 Polytar®  Liquid
    11.08.01 Polyvinyl Alcohol Liquifilm Tears or Sno Tears® Eye drops

    Brand with lowest aquisition cost will be supplied.
    08.02.04 Pomalidomide  Capsules
    03.05.02 Poractant Alfa Curosurf® Suspension

    Restricted Item Specialist neonatal use only
    05.02.01 Posaconazole Noxafil® Suspension
    Tablets

    Restricted Item Specialist (haematology) or ID consultant initiation only. See links
    For AML inpatients only. Not to be supplied on discharge
    11.99.99.99 Potassium Ascorbate  Eye drops

    unlicensedunlicensed
    09.02.01.01 Potassium Chloride Kay-Cee-L® Syrup
    09.02.01.01 Potassium Chloride Sando-K® Effervescent tablets
    09.02.02.01 Potassium Chloride 0.15% and Glucose 10% Intravenous Infusion  500ml bag (contains 10mmol of potassium)

    unlicensedUnlicensed special - manufactured to order and may not always be available
    09.02.02.01 Potassium Chloride 0.15% and Glucose 5% Intravenous Infusion  500ml bag (contains 10mmol of potassium)
    09.02.02.01 Potassium Chloride 0.15% and Sodium Chloride 0.9% Intravenous Infusion  500ml bag (contains 10mmol of potassium)
    09.02.02.01 Potassium Chloride 0.15%, Sodium Chloride 0.18% and Glucose 4% Intravenous Infusion  500ml bag (contains 10mmol of potassium)
    09.02.02.01 Potassium Chloride 0.15%, Sodium Chloride 0.45% and Glucose 5% Intravenous Infusion  500ml bag (contains 10mmol of potassium)
    09.02.02.01 Potassium Chloride 0.3% and Glucose 10% Intravenous Infusion  500ml bag (contains 20mmol of potassium)

    unlicensedUnlicensed special - manufactured to order and may not always be available
    09.02.02.01 Potassium Chloride 0.3% and Glucose 5% Intravenous Infusion  500ml bag (contains 20mmol of potassium)
    09.02.02.01 Potassium Chloride 0.3% and Sodium Chloride 0.9% Intravenous Infusion  500ml bag (contains 20mmol of potassium)
    09.02.02.01 Potassium Chloride 0.3%, Sodium Chloride 0.18% and Glucose 4% Intravenous Infusion  500ml bag (contains 20mmol of potassium)
    09.02.02.01 Potassium Chloride 0.3%, Sodium Chloride 0.45% and Glucose 10% Intravenous Infusion  500ml bag (contains 20mmol of potassium)

    09.02.02.01 Potassium Chloride 0.3%, Sodium Chloride 0.45% and Glucose 5% Intravenous Infusion  500ml bag (contains 20mmol of potassium)

    unlicensedUnlicensed special - manufactured to order and may not always be available
    09.02.02.01 Potassium Chloride 0.3%, Sodium Chloride 0.9% and Glucose 5% Intravenous Infusion  500ml bag (contains 20mmol of potassium)
    09.02.02.01 Potassium Chloride 0.6% and Glucose 5%  500ml bag (contains 40mmol of potassium)

    unlicensedUnlicensed special - manufactured to order and may not always be available

    Restricted Item 500ml bags containing 40mmol of potassium may be kept as stock in critical
    care areas. They will be supplied from the Pharmacy department to other wards
    on a named patient basis only.
    09.02.02.01 Potassium Chloride 0.6% and Sodium Chloride 0.9%  500ml bag (contains 40mmol of potassium)

    unlicensedUnlicensed special - manufactured to order and may not always be available

    Restricted Item 500ml bags containing 40mmol of potassium may be kept as stock in critical
    care areas. They will be supplied from the Pharmacy department to other wards
    on a named patient basis only.
    09.02.02.01 Potassium Chloride 15% Concentrate BP  10ml amps (Contains 20mmol potassium)

    Restricted Item Only the designated areas given in Appendix 1 of the Intravenous Potassium Policy have been authorised to stock and administer strong potassium chloride solutions as indicated. Potassium chloride concentrated solutions must never be transferred between clinical areas

    Must be stored in a Controlled Drugs cupboard.

    Must NEVER be administered undiluted
    (NPSA 'Never Event)
    09.02.02.01 Potassium Chloride 3% in Sodium Chloride 0.9%   100ml bag (contains 40mmol potassium)

    Restricted Item Only the designated areas given in Appendix 1 of the Intravenous Potassium Policy have been authorised to stock and administer strong potassium chloride solutions as indicated. Potassium chloride concentrated solutions must never be transferred between clinical areas

    Order as a Controlled Drug.

    Potassium chloride infusion 40mmol in 100ml sodium chloride 0.9% must be
    stored in a locked cupboard and kept separate from other infusion bags.
    07.04.03 Potassium Citrate Mixture BP  Oral solution
    13.11.06 Potassium Permanganate Permitabs® Solution tablets
    13.11.04 Povidone-Iodine Betadine® or Videne®
    04.09.01 Pramipexole  Tablets
    M/R tablets
    02.09 Prasugrel Efient® Tablets

    See information above, and GMMMG algorithms below.
    02.12 Pravastatin   Tablets
    05.05.03 PRAZIQUANTEL Tablets 500 mg  Tablets

    unlicensedunlicensed
    05.05.05 PRAZIQUANTEL Tablets 500 mg  Tablets

    unlicensedunlicensed
    01.05.02 Prednisolone  Tablets
    Soluble tablets
    Rectal foam
    Retention enema
    Suppositories


    Green Traffic Light  Enema and rectal foam = Green2

    06.03.02 Prednisolone  Tablets (NOT enteric coated)
    Restricted Item Soluble tablets - paediatrics only

    11.04.01 Prednisolone   Eye drops (0.5% and 1%)
    Single use eye drops 0.5% (Minims®)


    04.07.03 Pregabalin  Capsules

    note A trial of pregabalin may be considered in patients who cannot tolerate gabapentin, or who have not responded fully despite an adequate trial.
    04.08.01 Pregabalin  Capsules

    FOR EPILEPSY. See section 4.7.3 for use in neuropathic pain.
    06.01.05 Pregabalin  Capsules

    note A trial of pregabalin may be considered in patients who cannot tolerate gabapentin, or who have not responded fully despite an adequate trial.
    06.04.01.01 Premarin®  Tablets

    Conjugated oestrogen 300micrograms
    Conjugated oestrogen 625micrograms
    Conjugated oestrogen 1.25mg

    06.04.01.01 Premique®   Tablets

    Conjugated oestrogen 625micrograms + medroxyprogesterone acetate 5mg

    06.04.01.01 Premique® low dose  Tablets

    Conjugated oestrogen 300micrograms + medroxyprogesterone acetate 1.5mg

    06.04.01.01 Prempak-C®  Tablets

    Conjugated oestrogens 625micrograms + norgestrel 150micrograms
    Conjugated oestrogens 1.25mg + norgestrel 150micrograms

    05.04.01 Primaquine  Tablets
    05.04.08 Primaquine  Tablets
    04.08.01 Primidone  Tablets

    note Ensure patients are maintained on a specific manufacturer's product / brand
    04.09.03 Primidone  Tablets
    10.01.04 Probenecid  Tablets

    unlicensedunlicensed
    09.04 Procal  Dose calculated by dietitian
    04.06 Prochlorperazine  Tablets
    Buccal tablets (Buccastem®)
    Syrup
    Injection
    04.06 Prochlorperazine  Tablets
    Buccal tablets (Buccastem®)
    Syrup
    Injection
    04.06 Prochlorperazine  Tablets
    Buccal tablets (Buccastem®)
    Syrup
    Injection
    04.09.02 Procyclidine  Tablets
    Syrup
    Injection
    13.10.05 Proflavine Cream, BPC   Cream
    06.04.01.02 Progesterone Cyclogest® Pessaries/suppositories

    "Red" when used for infertility
    06.04.01.02 Progesterone Gestone® Injection
    05.04.01 Proguanil Hydrochloride  Tablets
    05.04.01 Proguanil Hydrochloride with Atovaquone Malarone® Tablets
    04.02.01 Promazine Hydrochloride  Tablets
    Oral solution

    note Only licensed for agitation
    03.04.01 Promethazine  Tablets
    Elixir
    Injection

    04.01.01 Promethazine Hydrochloride  Tablets
    Elixir
    Injection
    04.06 Promethazine Hydrochloride  Tablets
    Elixir
    Injection
    04.06 Promethazine Hydrochloride  Tablets
    Elixir
    Injection
    02.03.02 Propafenone 
    11.03.01 Propamidine Isetionate Brolene® Eye drops

    Restricted Item Used with chlorhexidine for treatment of acanthamoeaba keratitis only
    15.01.01 Propofol 
    02.04 Propranolol  Tablets
    Modified Release Capsules
    Liquid

    04.07.04.02 Propranolol  Tablets
    M/R capsules
    Oral solution
    04.09.03 Propranolol  Tablets
    M/R capsules
    Oral solution
    06.02.02 Propylthiouracil  Tablets
    Prescribing to remain with specialist care until stable.
    02.08.03 Protamine Sulphate  Injection
    05.01.09 Prothionamide  Tablets


    unlicensedunlicensed

    Restricted Item Can only be prescribed following discussion with an ID physician
    11.07 Proxymetacaine Hydrochloride Minims® Single-use eye drops
    03.10 Pseudoephedrine Hydrochloride  Tablets
    Elixir
    13.05.02 Psoriderm® Coal tar 6% Cream
    05.01.09 Pyrazinamide  Tablets
    10.02.01 Pyridostigmine Bromide  Tablets
    05.01.09 Pyridoxine  Tablets
    09.06.02 Pyridoxine Hydrochloride  Tablets
    Injection
    Oral Solution unlicensedunlicensed
    05.04.01 Pyrimethamine  Tablets
    05.04.07 Pyrimethamine  Tablets
    04.02.01 Quetiapine  Tablets
    M/R tablets
    05.04.01 Quinine  Tablets
    Injection
    10.02.02 Quinine Sulphate  Tablets
    13.02.01 QV®  Skin lotion
    Cream
    Intensive ointment

    Restricted Item Only on advice of tissue viability
    13.02.01.01 QV®  Bath oil
    Gentle wash

    Restricted ItemOnly on advice of tissue viability
    14.05.02 Rabies Immunoglobulin  Medical team to contact Clinical Virology at Central Manchester Foundation Trust (0161 276 8853)
    14.04 Rabies vaccine  Pre-exposure vaccination: NMGH Travel Clinic only
    06.04.01.01 Raloxifene Hydrochloride Evista® Tablets
    05.03.01 Raltegravir Isentress ®
    02.05.05.01 Ramipril  Capsules
    11.08.02 Ranibizumab Lucentis® Intravitreal injection

    Restricted Item Ophthalmic consultant only

    Use as per GMMMG Macular Drugs Pathway
    01.03.01 Ranitidine  Tablets
    Effervesent tablets
    Syrup
    Injection
    02.06.03 Ranolazine Ranexa® Tablets

    Restricted Item Restricted to cardiac services (PAHT)

    For stable angina where patients are unsuitable for physical therapy or first and second line agents (PAHT).
    10.01.04 Rasburicase Fastertec® Intravenous infusion
    04.03.04 Reboxetine 
    15.01.04.03 Remifentanil Ultiva®
    06.01.02.03 Repaglinide Prandin® Tablets
    04.08.01 Retigabine  Tablets

    05.03.03.02 Ribavirin Copegus® Tablets
    05.01.09 Rifabutin Mycobutin® Capsules

    Restricted Item Can only be prescribed following discussion with an ID Physician
    05.01.09 Rifampicin  Capsules
    Tablets
    Syrup
    Intravenous Infusion

    No restrictions on use for non-tuberculosis indications.
    05.01.09 Rifampicin and Isoniazid Rifinah® Tablets

    For continuation (maintenance) phase of treatment
    05.01.09 Rifampicin and Isoniazid and Pyrazinamide Rifater® Tablets

    2nd line option with a 4th agent
    05.01.09 Rifampicin, isoniazid, pyrazinamide and ethambutol Voractiv® Tablets
    05.01.07 Rifaximin  Restricted Item Gastroenterologists only

    Initial 2 weeks supply provided by secondary care.
    05.03.01 Rilpivirine hydrochloride Edurant®
    04.09.03 Riluzole  Tablets
    11.04.01 Rimexolone Vexol® Eye drops
    06.06.02 Risedronate   35mg tablets (once weekly preparation)
    04.02.01 Risperidone  Tablets
    Orodispersible tablets
    Liquid
    04.02.02 Risperidone Risperdal Consta®
    05.03.01 Ritonavir Norvir®
    08.02.03 Rituximab MabThera® Concentrate for intravenous infusion

    Restricted Item Specialist use only
    10.01.03 Rituximab  Intravenous Infusion
    24.03 Rituximab IV Infusion 
    24.03 Rituximab SC Injection 
    02.08.02 Rivaroxaban Xarelto® Tablets
    02.08.02 Rivaroxaban Xarelto® Tablets
    02.08.02 Rivaroxaban Xarelto® Tablets
    04.11 Rivastigmine  Capsules
    Oral solution
    Patch

    Green Traffic Light Commissioning arrangements may vary and in some localities this is Green2 - check with relevant CCG
    15.01.05 Rocuronium Bromide Esmeron®
    03.03.03 Roflumilast Daxas® Tablets
    09.01.04 Romiplostim Nplate® Injection

    PbR excluded - commissioned by CCG
    Prescribers need to ensure manufacturer makes romiplostim available with the discount agreed as part of the patient access scheme.
    04.09.01 Ropinirole  Tablets
    M/R tablets
    02.12 Rosuvastatin  Tablets

    Approved for use in PAHNT for patients who have not achieved target levels with other statins.
    14.04 Rotavirus vaccine Rotarix®
    04.09.01 Rotigotine Patch  Only for patients unable to tolerate or comply with oral medication.
    04.08.01 Rufinamide 
    04.09.01 Safinamide Xadago Tablet
    03.01.01.01 Salbutamol  Dry powder inhaler (DPI)(Easyhaler®)
    Breath-actuated inhaler (Airomir® Autohaler, Salamol Easi-breathe®)
    Dry powder inhaler(Ventolin®Accuhaler)
    03.01.01.01 Salbutamol  Inhalers (see separate entries)
    Nebuliser solution
    Tablets
    Oral solution
    Injection
    Solution for infusion


    Restricted Item The use of short-acting adrenoreceptor agonists for tocolyis in premature labour has been restricted to 48 hours maximum parenteral use under specialist supervision, after a European safety review (MHRA 2013 - see Drug Safety Update)
    03.01.01.01 Salbutamol  Brands include Ventolin Evohaler®, Airomir® inhaler.
    07.01.03 Salbutamol  Injection
    13.07 Salicylic Acid 16.7% with Lactic Acid 16.7% Salactol®or Duofilm® Paint
    01.01 Salicylic Acid Ointment  Ointment
    13.10.02 Salicylic Acid Ointment  Ointment
    03.01.01.01 Salmeterol  Metered dose inhaler 25 micrograms/dose (Serevent Evohaler®)
    Dry powder inhaler (Serevent Accuhaler®)

    09.06.07 Sanatogen A-Z  Tablets
    24.03 Savene IV Infusion 
    06.01.02.03 Saxagliptin Onglyza® Tablets

    note For established patients only. Alogliptin is first line.
    01.07.02 Scheriproct®   Ointment
    Suppositories
    13.05.02 Sebco®  Scalp Ointment
    10.01.03 Secukinumab Cosentyx® Pre-filled syringe

    Supplied via homecare arrangements
    13.05.03 Secukinumab Cosentyx®
    04.09.01 Selegiline Hydrochloride  Tablets
    13.09 Selenium Sulphide 2.5% Shampoo Selsun® Shampoo
    01.06.02 Senna  Tablets
    Syrup
    04.03.03 Sertraline  Tablets
    09.05.02.02 Sevelamer Hydrochloride  Renagel® Tablets
    15.01.02 Sevoflurane 
    02.05.01 Sildenafil  Tablets (Revatio®)
    Suspension (paediatric use) unlicensedunlicensed

    Formulary for treatment of pulmonary arterial hypertension.

    For erectile dysfunction, see chapter 7.4.5.
    07.04.05 Sildenafil  Tablets
    13.07 Silver Nitrate 95% with Potassium Nitrate 5% AVOCA® Caustic Applicator (stick)
    13.10.01.01 Silver Sulfadiazine 1% Cream Flamazine® Cream
    01.01.01 Simeticone infacol®
    09.04 Similac alimentum  Dose dependent on age
    09.04 Similac High Energy  Dose dependent on age
    03.09.02 Simple Linctus, BP  Oral solution
    03.09.02 Simple Linctus, Paediatric BP  Oral solution
    02.12 Simvastatin  Tablets
    13.02.02 Siopel®  Cream
    06.01.02.03 Sitagliptin Januvia® Tablets

    note For established patients only. Alogliptin is first line.

    10.01.03 Sodium Aurothomalate Myocrisin® Injection
    09.08.01 Sodium Benzoate  
    07.04.03 Sodium Bicarbonate  Capsules
    Tablets
    09.02.01.03 Sodium Bicarbonate  Capsules
    Tablets

    09.02.02.01 Sodium Bicarbonate Polyfusor® 1.26%
    1.4%
    4.2%
    8.4%
    09.02.02.01 Sodium Bicarbonate Minijet® 4.2% 10ml Minijet
    8.4% 10ml Minijet
    8.4% 50ml Minijet
    09.02.02.01 Sodium Bicarbonate  4.2% 5ml amps unlicensedunlicensed
    4.2% 10ml amps unlicensedunlicensed
    8.4% 10ml amps
    12.01.03 Sodium Bicarbonate  Ear drops
    09.02.01.02 Sodium Chloride Slow Sodium® Modified release tablets
    09.02.02.01 Sodium Chloride 0.18% and Glucose 10% Intravenous Infusion  500ml bag
    09.02.02.01 Sodium Chloride 0.18% and Glucose 4% Intravenous Infusion  500ml bag
    1L bag
    09.02.02.01 Sodium Chloride 0.45% and Glucose 10% Intravenous Infusion  500ml bag
    09.02.02.01 Sodium Chloride 0.45% and Glucose 5% Intravenous Infusion  500ml bag
    09.02.02.01 Sodium Chloride 0.45% Infusion  500ml bag
    03.01.05 Sodium Chloride 0.9%  Nebuliser solution
    13.11.01 Sodium Chloride 0.9%  Solution
    09.02.02.01 Sodium Chloride 0.9% and Glucose 5% Intravenous Infusion  500ml bag
    1L bag
    09.02.02.01 Sodium Chloride 0.9% Infusion  50ml bag
    100ml bag
    250ml bag
    500ml bag
    500ml polyfusor
    1L bag
    09.02.02.01 Sodium Chloride 0.9% Injection  2ml amps
    5ml amps
    10ml amps
    20ml amps
    12.02.02 Sodium Chloride 0.9% Nose Drops  Nose drops
    11.08.01 Sodium Chloride 0.9% Solutions  Single-use eye drops
    11.99.99.99 Sodium Chloride 5%  Preservative-free Eye drops

    unlicensedunlicensed
    12.03.04 Sodium Chloride Mouthwash, Compound BP  Mouthwash
    09.02.02.01 Sodium Chloride Polyfusor (500ml)  0.18%
    0.9%
    1.8%
    2.7%
    5%
    01.06.04 Sodium Citrate Micro-enema® 
    06.06.02 Sodium Clodronate  Tablets

    Restricted Item Specialist Initiation Only
    11.04.02 Sodium Cromoglicate  Eye drops
    09.01.01.01 Sodium Feredetate Sytron® 27.5mg iron per 5ml
    05.01.07 Sodium fusidate  Tablets
    Oral Suspension
    Injection Restricted Item ID/microbiologist recommendation only
    11.08.01 Sodium Hyaluronate  Eye drops (brand with lowest aquisition cost will be supplied)
    1.2% syringe (BVI OVD®)
    2.5% syringe (BVI Multivisc®)

    02.05.01 Sodium Nitroprusside  Intravenous infusion

    unlicensedunlicensed
    09.08.01 Sodium Phenybutyrate Ammonaps®
    01.06.02 Sodium Picosulfate  Elixir
    01.06.05 Sodium Picosulfate with Magnesium Citrate Citrafleet® or Picolax®
    05.04.05 Sodium Stibogluconate Pentostam® Injection
    02.13 Sodium Tetradecyl Sulphate Fibro-Vein® Injection
    04.08.01 Sodium Valproate  Tablets (e/c)
    Crushable tablets
    M/R tablets
    Syrup
    Injection
    05.03.03.02 Sofosbuvir Sovaldi® Tablets

    Restricted Item  Requires MDT discussion with ID team
    05.03.03.02 Sofosbuvir / Velpatasvir Epclusa® Tablets

    Restricted Item  Requires MDT discussion with ID team
    07.04.02 Solifenacin  Tablets
    02.04 Sotalol  Tablets

    Restricted Item Specialist initiation

    Sotalol is an option for managing life-threatening arrhythmias.
    02.02.03 Spironolactone  Tablets
    Suspension

    Spironolactone is significantly cheaper than eplerenone but there is no data available to compare cost-effectivess in particular groups of patients.
    13.02.02 Sprilon®  Spray
    05.03.01 Stavudine Zerit® Capsules
    Oral Solution

    Restricted Item Only for patients already established on this treatment
    01.06.01 Sterculia Normacol® Granules
    02.10.02 Streptokinase  Injection
    05.01.09 Streptomycin Sulphate  Intramuscular Injection

    Restricted Item Can only be prescribed following discussion with an ID physician.
    06.06.02 Strontium Ranelate Protelos® Granules

    Restricted Item Specialist Initiation Only
    01.03.03 Sucralfate Antepsin® Tablets
    Suspension

    note Following reports of bezoar formation associated with sucralfate, caution is advised in seriously ill patients, especially those receiving concomitant enteral feeds or those with predisposing conditions such as delayed gastric emptying

    13.02.02 Sudocrem®  Cream
    15.01.06 Sugammadex Bridion®
    05.01.08 Sulfadiazine  Tablets

    Restricted Item  Can only be prescribed following discussion with ID Physician. See BHIVA Guidelines
    05.04.07 Sulfadiazine  Tablets

    Restricted Item Can only be prescribed following discussion with an ID physician
    01.05.01 Sulfasalazine  Tablets
    Suspension
    10.01.03 Sulfasalazine  Enteric coated tablets
    10.01.04 Sulfinpyrazone  Tablets
    04.02.01 Sulpiride  Tablets
    Oral solution
    04.07.04.01 Sumatriptan  Tablets
    Injection
    04.07.04.03 Sumatriptan  Injection
    13.08.01 Sunsense® Ultra SPF 50+  Lotion

    Preparations with an SPF less than 30 should not be prescribed.
    15.01.05 Suxamethonium Chloride 
    13.09 T/Gel® Therapeutic Shampoo Coal tar extract 2% Shampoo
    13.05.02 Tacalcitol Curatoderm® Lotion
    Ointment

    Restricted Item To be commenced on advice of dermatology only
    08.02.02 Tacrolimus  Capsules
    Granules
    Modified-release capsules
    Concentrate for intravenous infusion

    note Prescribe by brand. Do not switch between brands.

    There are 3 different oral formulations of tacrolimus:
  • Adoport®, Prograf®, Capexion®, Tacni®, and Vivadex® are immediate-release capsules that are taken twice daily, once in the morning and once in the evening;
  • Modigraf® granules are used to prepare an immediate-release oral suspension which is taken twice daily, once in the morning and once in the evening;
  • Advagraf® is a prolonged-release capsule that is taken once daily, in the morning.
  • 13.05.03 Tacrolimus Protopic® 0.03% Ointment
    0.1% Ointment

    Restricted Item Consultant Dermatologist only

    08.03.04.01 Tamoxifen  Tablets

    07.04.01 Tamsulosin  Capsules
    04.07.02 Tapentadol SR Palexia SR®

    Prolonged release tablets

    • Third or fourth line option in those patients who have failed other therapies and are intolerant to oxycodone.
    • To be prescribed or initiated under the advice of a specialist in pain management only.

      Grey Traffic Light Use of this agent should be restricted to those patients requiring treatment of severe chronic pain which CANNNOT be managed with more established opioid therapies.
    05.01.07 Teicoplanin  Injection
    04.01.01 Temazepam  Tablets
    Oral solution
    15.01.04.01 Temazepam 
    05.01.01.02 Temocillin Negaban®

    Intravenous injection

    For use in hospital-acquired UTIs in paediatrics - see policy

    Restricted Item Restricted in adults - contact Microbiology for advice

    02.10.02 Tenecteplase Metalyse® Injection
    05.03.01 Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg Atripla®
    05.03.01 Tenofovir alafenamide and Emtricitabine Descovy® Restricted ItemRequires MDT discussion with ID team
    05.03.01 Tenofovir alafenamide, Emtricitabine and Rilpivirine Odefsey® Tablet

    Restricted ItemRequires MDT discussion with ID team
    05.03.01 Tenofovir alafenamide, Emtricitabine, Elvitegravir and Cobicistat Genvoya® Tablet

    Restricted ItemRequires MDT discussion with ID team
    05.03.01 Tenofovir and Emtricitabine Truvada®
    05.03.01 Tenofovir Disproxil Viread®
    05.03.03.01 Tenofovir Disproxil Viread®
    05.03.01 Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild® Tablets

    Restricted Item Requires MDT discussion with ID team
    05.02.05 Terbinafine  Tablets

    Restricted Item Dermatology only
    13.10.02 Terbinafine 1% cream  Cream
    03.01.01.01 Terbutaline  Dry powder inhaler (DPI)(Bricanyl® Turbohaler)
    03.01.01.01 Terbutaline  Inhaler (see separate entry)
    Nebuliser solution 5mg/2ml (Respules®)
    07.01.03 Terbutaline  Injection
    06.06.01 Teriparatide Forsteo® Injection

    Restricted Item 2nd line treatment for severe osteoporosis in accordance with NICE guidance. For specialist use only

    PbR excluded - commissioned by CCG
    06.05.02 Terlipressin Glypressin® Injection
    06.04.02 Testosterone enantate  IM injection
    06.04.02 Testosterone gel  Testogel® Gel
    06.04.02 Testosterone gel  Tostran® Gel
    06.04.02 Testosterone implant  Implant
    06.04.02 Testosterone oral Restandol Testocaps® Capsules
    06.04.02 Testosterone undecanoate  IM injection
    14.05.02 Tetanus immunoglobulin 

    Treatment of clinical tetanus: IV tetanus immunoglobulin no longer available - use IV human normal immunoglobulin (eg: Octagam® 10%)

    Prophylaxis of tetanus-prone wounds: There are intermittent supply problems with IM tetanus immunoglobulin - use Subgam® human normal immunoglobulin SC/IM

    See Public Health England (PHE) Guidance for full details

     

    04.09.03 Tetrabenazine  Tablets
    11.07 Tetracaine Hydrochloride Minims® Amethocaine Hydrochloride Single-use eye drops
    06.05.01 Tetracosactide Synacthen® 250 microgram/ml injection (for short 30-minute test)
    1mg/ml depot injection (for 5-hour test)
    05.01.03 Tetracycline  Tablets
    05.01.10 Thalidomide  Tablets

    Restricted Item Approved for use by ID physicians only for patients who have steroid dependent Immune Reconsitution Syndrome (IRIS) secondary to HIV related opportunistic infection or meningeal tuberculosis in a non-HIV patient. unlicensedunlicensed use
    08.02.04 Thalidomide Thalidomide Celgene® Capsules
    03.01.03 Theophylline  Modified release tablets (Nuelin SA®, Uniphyllin Continus®)
    Modified release capsules (Slo-Phyllin®)

    Specify brand when prescribing.
    09.06.02 Thiamine  Tablets
    05.01.09 Thioacetazone  unlicensedunlicensed

    Restricted Item Can only be prescribed following discussion with an ID physician
    15.01.01 Thiopental 
    24.03 Thiotepa IV Infusion 
    05.05.07 TIABENDAZOLE 500mg tabs  Tablet

    unlicensedunlicensed
    04.08.01 Tiagabine  Tablets
    06.04.01.01 Tibolone Livial® Tablets
    02.09 Ticagrelor Brilique® Tablets

    See information above.

    Restricted Item Only to be prescribed on advice of cardiology
    05.01.01.04 Ticarcillin with Clavulanic Acid Timentin® Injection
    14.04 Tick-borne encephalitis vaccine  Restricted Item NMGH Travel Clinic only
    05.01.03 Tigecycline  Intravenous Infusion

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist or ID Physician
    11.06 Timolol  Eye drops
    Unit dose eye drops
    Long acting gel drops (Timolol LA®)
    05.01.11 Tinidazole Fasigyn® Tablets
    05.04.02 Tinidazole  See section 5.1.11
    03.01.02 Tiotropium Spiriva® Inhalation powder, hard capsule for use with Handihaler® device, 18 micrograms.
    Respimat® inhaler 2.5 micrograms/dose.

    The Spiriva Respimat device should be used with caution in patients with known cardiac rhythm disorders - see SPC
    03.01.04 Tiotropium / Olodaterol Spiolto® Respimat Metered dose inhaler
    Combination LABA/LAMA inhaler
    05.03.01 Tipranavir Aptivus®
    02.09 Tirofiban Aggrastat® Concentrate for infusion
    10.02.02 Tizanidine  Tablets
    05.01.04 Tobramycin  Injection
    Dry powder inhaler ("'Podhaler'")
    Nebuliser solution

    Restricted Item Can only be prescribed for intravenous use following discussion with the Consultant Microbiologist or ID Physician
    Restricted Item Injection solution can be nebulised in non-CF bronchiectasis; at the request of a Consultant Respiratory Physician only
    10.01.03 Tocilizumab  Intravenous preparation ONLY

    (Subcutaneous preparation is currently non-formulary)
    24.03 Tocilizumab IV Infusion 
    07.04.02 Tolterodine  Tablets
    M/R capsules
    06.05.02 Tolvaptan Samsca® Tablets


    04.07.04.02 Topiramate  Tablets
    Sprinkle® capsules

    Grey Traffic Light Topiramate hard capsules are expensive and should not be prescribed. For those patients unable to swallow topiramate tablets “sprinkle capsules” may be considered
    04.08.01 Topiramate  Tablets
    Sprinkle® capsules

    Grey Traffic Light Topiramate hard capsules are expensive and should not be prescribed. For those patients unable to swallow topiramate tablets “sprinkle capsules” may be considered
    02.02.02 Torasemide  Tablets
    04.07.02 Tramadol  Capsules
    Soluble tablets
    M/R tablets or capsules
    Injection
    02.11 Tranexamic Acid  Tablets
    Injection
    12.03.04 Tranexamic Acid Mouthwash  unlicensedunlicensed
    10.03.02 Transvasin  Heat rub cream
    04.03.02 Tranylcypromine 
    11.06 Travoprost Travatan® Eye drops

    Does not contain benzalkonium chloride as the preservative and therefore may be used in patients where a known allergy to benzalkonium chloride exists.

    11.06 Travoprost with Timolol DuoTrav® Eye drops

    Does not contain benzalkonium chloride as the preservative and therefore may be used in patients where a known allergy to benzalkonium chloride exists.

    Combination products are licensed for once daily use where prostaglandin analogue alone is not adequate. Only use where patient has difficulty with compliance/administration.
    04.03.01 Trazodone  Capsules
    Tablets
    Liquid
    06.01.01.02 Tresiba® Insulin degludec 3ml cartridges (via Novo Nordisk® devices)
    3ml pre-filled disposable pen (Flextouch®)

    **Only the 100units/mL strength has been approved by the Division of Medicine. Use of the 200units/ml strength requires named-patient approval from Medical D&T Committee Chair**
    06.03.02 Triamcinolone Kenalog® Injection
    10.01.02.02 Triamcinolone Acetonide  Injection
    13.04 Triamcinolone Acetonide 0.1% with Chlortetracycline Hydrochloride 3% Aureocort® Ointment
    13.07 Trichloroacetic Acid  Solution
    13.11.05 Triclosan 2% Aquasept® Usage has been replaced by Hibiscrub
    04.02.01 Trifluoperazine  Tablets
    Oral solution 5mg/5mL
    Syrup 1mg/5mL
    04.09.02 Trihexyphenidyl  Tablets
    Syrup
    05.01.08 Trimethoprim  Tablets
    Oral Suspension

    05.01.13 Trimethoprim  See section 5.1.8.
    07.03.01 TriNovum® Ethinylestradiol / norethisterone phased pill Tri-phasic preparation
    01.03.03 Tripotassium Dicitratobismuthate De-Noltab® Restricted Item  H.pylori eradication only
    11.05 Tropicamide Mydriacyl® 0.5% and 1% Eye drops
    0.5% and 1% single-use eye drops (Minims®)
    07.04.02 Trospium  Tablets
    M/R capsules
    04.03.04 Tryptophan 
    09.04.02 Two Cal  
    06.04.01.02 Ulipristal Esmya® Tablets
    07.03.05 Ulipristal EllaOne®
    03.01.02 Umeclidinium Incruse Ellipta
    03.01.04 Umeclidinium / Vilanterol Anoro® Ellipta Combination LABA/LAMA inhaler
    13.02.01 Unguentum M®  Cream

    Restricted Item Dermatology only
    13.11.02 Unisept® Chlorhexidine Gluconate 0.05% Sachets
    02.10.02 Urokinase  Injection
    01.09.01 Ursodeoxycholic acid  Capsules
    Suspension
    10.01.03 Ustekinumab  Subcutaneous Injection

    Supplied via homecare arrangements

    Approved for use as per NICE TA340, i.e.:

    Ustekinumab is recommended as an option, alone or in combination with methotrexate, for treating active psoriatic arthritis in adults only when:
    • treatment with TNF alpha inhibitors is contraindicated but would otherwise be considered (as described in NICE guidance on etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis and golimumab for the treatment of psoriatic arthritis)
    • or the person has had treatment with 1 or more TNF–alpha inhibitors.

    Ustekinumab is recommended only if the company provides the 90mg dose of ustekinumab for people who weigh more than 100 kg at the same cost as the 45mg dose, as agreed in the patient access scheme.
    13.05.03 Ustekinumab  NICE and GMMMG recommend ustekinumab as an option, alone or in combination with methotrexate, for treating active psoriatic arthritis in adults only when:
    • treatment with TNF alpha inhibitors is contraindicated but would otherwise be considered
    • or the person has had treatment with 1 or more TNF–alpha inhibitors.

    Consideration should be given to discontinuing treatment in patients who have shown no response up to 28 weeks of treatment.

    Available via Patient Access Scheme: please contact pharmacy for details
    13.08.01 Uvistat®  Cream
    Ultrablock Cream

    Preparations with an SPF less than 30 should not be prescribed.
    05.03.02.01 Valaciclovir Valtrex® Tablets

    Restricted Item Can only be prescribed on advice of ID physician or virologist
    05.03.02.02 Valganciclovir Valcyte®
    04.02.03 Valproic Acid Depakote® Tablets
    02.05.05.02 Valsartan  Tablets

    GMMMG endorse use in post-myocardial infarction.
    02.05.05.02 Valsartan / Sacubitril Entresto® Tablets

    Restricted ItemTo be initiated by Heart Failure team
    05.01.07 Vancomycin  Capsules
    Injection


    Green Traffic Light  Green1 for severe or recurrent C.diff only. To be used on advice of microbiology for other indications

    24.01 Vancomycin IV Infusion  500mg
    750mg
    1000mg
    1250mg
    1500mg
    2000mg
    24.01 Vancomycin IV Syringe for neonatal use 40mg in 8mL sodium chloride 0.9%
    80mg in 16mL sodium chloride 0.9%
    14.05.02 Varicella-Zoster immunoglobulin  Medical team to contact Clinical Virology at Central Manchester Foundation Trust (0161 276 8853)
    14.04 Varicella-zoster vaccine Varivax®
    06.05.02 Vasopressin Pitressin® Injection
    15.01.05 Vecuronium Bromide Norcuron®
    01.05.03 Vedolizumab Entyvio®
    24.03 Vedolizumab IV Infusion 
    04.03.04 Venlafaxine  Tablets
    M/R tablets or capsules
    02.06.02 Verapamil  Standard tablets
    Modified release tablets
    Modified release capsules
    Injection

    04.08.01 Vigabatrin  Tablets
    Powder sachets
    24.03 Vinblastine IV Infusion 
    24.03 Vincristine IV Infusion 
    18 Viper Venom antisurem 
    09.04.02 Vital 1.5kcal 
    09.04 Vital 1.5kcal 200ML 
    09.06.02 Vitamin B Tablets (Compound)  Tablets
    09.06.02 Vitamin B Tablets, Compound Strong  Tablets

    For the prevention of re-feeding syndrome only
    09.06.01 Vitamins A and D  Capsules

    unlicensedunlicensed
    05.02.01 Voriconazole Vfend® Tablets
    Oral Suspension
    Intravenous Infusion

    Restricted Item Can only be prescribed following discussion with the Consultant Microbiologist, ID Physician or Haematologist
    02.08.02 Warfarin  Tablets
    02.08.02 Warfarin  Tablets
    13.02.01 White Soft Paraffin BP  Ointment
    12.02.02 Xylometazoline Otrivine® Nasal drops
    01.07.02 Xyloproct®  Ointment
    14.04 Yellow fever vaccine (Live)  NMGH Travel Clinic only
    13.02.01 Yellow Soft Parrafin BP  Jelly
    05.03.04 Zanamivir inhalation Relenza® Dry powder for inhalation
    07.03.02 Zelleta® Desogestrel 75mcg Tablets
    13.02.01 Zerobase®  Cream
    05.03.01 Zidovudine Retrovir® Capsules
    Oral Solution
    Injection
    05.03.01 Zidovudine and Lamivudine Combivir®
    13.05.02 Zinc and Salicylic Acid Paste BP Lassar's Paste Paste

    unlicensedunlicensed
    09.05.04 Zinc Sulphate Solvazinc® Effervescent tablets
    06.06.02 Zoledronic Acid Zometa® Intravenous infusion

    note For reduction of bone damage in advanced malignancies involving bone, and hypercalcaemia of malignancy
    06.06.02 Zoledronic Acid Aclasta® Intravenous infusion

    note For:
    Paget's disease of bone,
    Postmenopausal osteoporosis (Restricted ItemSee GMMMG NTS recommendation),
    and osteoporosis in men
    04.01.01 Zolpidem  Tablets
    04.08.01 Zonisamide  Capsules
    04.01.01 Zopiclone  Tablets
    04.02.01 Zuclopenthixol  Tablets
    04.02.01 Zuclopenthixol Acetate injection Clopixol Acuphase®
    04.02.02 Zuclopenthixol Decanoate Clopixol®
    The Pennine Acute Hospitals